Cardiodefibrillation

CARDIOVERSION

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Operations: NOMESCO codes — ^TFP20 1 out of 7 registries used, show all original rules.	17977
4. Check minimum number of events None	17977
5. Include endpoints None	17977
6. Filter based on genotype QC (FinnGen only)	16365

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF4

NAME	CARDIOVERSION
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM	^TFP20
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cardiodefibrillation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	16365	5693	10672
Unadjusted period prevalence (%)	3.89	2.02	4.89
Median age at first event (years)	66.68	69.33	65.26

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
16764: Matched controls
167122

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WX402

NOMESCO Finland

General anaesthesia

2.5

307.7

4814

23459

TFP34

NOMESCO Finland

Electrophysiological investigation

22.3

307.7

2630

1384

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

307.7

4308

23362

K78

ICPC

Atrial fibrillation/flutter

9.6

307.7

5513

8102

C07AA07

ATC

sotalol; systemic

7.0

307.7

1924

3055

K04

ICPC

Palpitations/awareness of heart

3.6

307.7

1354

4021

AN1

Coronary angiography

2.4

307.7

3150

14785

AR5

Catheter ablation of arrhythmia, target: atrial flutter

27.2

307.7

277

103

K05

ICPC

Irregular heartbeat other

4.4

307.7

1112

2679

I50.0

ICD-10 Finland

Congestive heart failure

3.9

307.7

3022

8937

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

9.1

307.7

782

890

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

307.7

3797

18790

C03DA01

ATC

spironolactone; oral

3.4

307.7

4205

15021

XF402

NOMESCO Finland

ECG with work load test

2.6

307.7

2868

12254

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

11.5

307.7

10131

19541

I48.1

ICD-10 Finland

Persistent atrial fibrillation

9.5

307.7

3326

4254

ZXE00

NOMESCO Finland

One hour or less

2.3

307.7

7691

44933

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

6.7

307.7

620

952

B01AF03

ATC

edoxaban; oral

4.6

307.7

932

2099

XF400

NOMESCO Finland

ECG with 12 standard connections

3.2

307.7

4650

17948

B01AE07

ATC

dabigatran etexilate; oral

6.9

307.7

2078

3364

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

5.2

307.7

1742

3672

C07AB07

ATC

bisoprolol; oral

11.6

307.7

15087

72827

B01AF01

ATC

rivaroxaban; oral

3.7

307.7

4631

15609

I47.1

ICD-10 Finland

Supraventricular tachycardia

4.1

307.7

1278

3265

TPH04

NOMESCO Finland

Cathetrisation of vein

2.6

307.7

5511

26790

WX892

NOMESCO Finland

Monitored bed care

2.8

307.7

2122

8141

K80

ICPC

Cardiac arrhythmia NOS

4.3

307.7

3042

8151

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

4.1

307.7

6784

23576

I48.3

ICD-10 Finland

Typical atrial flutter

13.5

307.7

836

647

I48

ICD-10 Finland

Atrial fibrillation and flutter

54.5

307.7

15340

27561

WX902

NOMESCO Finland

External defibrillation of heart

40.0

307.7

354

R06.0

ICD-10 Finland

Dyspnoea

2.0

307.7

5728

34864

I50.9

ICD-10 Finland

Heart failure, unspecified

4.0

307.7

5772

19200

I48.2

ICD-10 Finland

Chronic atrial fibrillation

8.4

307.7

3257

4641

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

4.8

307.7

823

1777

C07AB02

ATC

metoprolol; systemic

2.2

307.7

4809

25928

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

4.2

307.7

8262

31539

AQ1

Conventional electrophysiological examination

12.7

307.7

626

509

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

3.2

307.7

1663

5636

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

4.9

307.7

3093

7317

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

8.1

307.7

5279

8949

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

5.2

307.7

1894

3987

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

5.8

307.7

813

1467

C08DA01

ATC

verapamil; systemic

4.2

307.7

1292

3234

I49.5

ICD-10 Finland

Sick sinus syndrome

4.7

307.7

1607

3673

XF404

NOMESCO Finland

Ambulatory ECG

5.5

307.7

3792

8471

ZXD05

NOMESCO Finland

Urgent procedure

2.3

307.7

6226

33990

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.7

307.7

2833

11603

I34.1

ICD-10 Finland

Mitral (valve) prolapse

5.1

307.7

1017

2104

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.7

307.7

6846

34011

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

9.2

307.7

415

458

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

3.6

307.7

1512

4483

I50.1

ICD-10 Finland

Left ventricular failure

4.1

307.7

1950

5250

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.8

307.7

1383

3906

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.1

307.7

11705

71222

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

4.9

307.7

2290

5260

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

10.7

307.7

6341

8991

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

37.6

307.7

1346

387

C01AA05

ATC

digoxin; systemic

9.3

307.7

5094

7467

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

9.7

307.7

460

485

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

14.3

307.7

11407

21676

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

6.6

307.7

3394

6163

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.5

307.7

3109

10173

C01BC04

ATC

flecainide; systemic

21.8

307.7

3331

1882

C03CA01

ATC

furosemide; systemic

3.4

307.7

9439

45831

Z2221

NOMESCO Finland

Medical doctor

2.0

307.7

4962

29172

201

Kela drug reimbursment

Chronic cardiac insufficiency

4.2

307.7

2258

5914

207

Kela drug reimbursment

Chronic arrhythmias

16.9

307.7

11562

19421

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

6.0

307.7

675

1157

342

Kela drug reimbursment

Dronedarone

36.2

307.7

747

215

AR6

Catheter ablation of arrhythmia, target: atrial fibrillation

56.5

307.7

463

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

25.0

307.7

444

182

I48.4

ICD-10 Finland

Atypical atrial flutter

16.8

307.7

469

286

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

58.9

307.7

1896

361

TFP45

NOMESCO Finland

Ablation treatment of non-typical atrial flutter

107.6

307.7

171

TFP20

NOMESCO Finland

Cardiodefibrillation

+∞

307.7

16764

B01AA03

ATC

warfarin; systemic

9.4

307.7

10205

23663

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

4.3

307.7

898

2151

I47.2

ICD-10 Finland

Ventricular tachycardia

5.3

307.7

819

1597

C01BD01

ATC

amiodarone; systemic

22.9

307.7

3047

1607

I42.0

ICD-10 Finland

Dilated cardiomyopathy

4.7

307.7

1019

2287

B01AF02

ATC

apixaban; oral

6.1

307.7

6926

17407

C09AA05

ATC

ramipril; oral

1.9

307.7

5892

36673

WX404

NOMESCO Finland

Intravenous generell anesthesy

5.4

307.7

6502

17543

C01BD07

ATC

dronedarone; oral

34.4

307.7

609

183

I50

ICD-10 Finland

Heart failure

4.1

307.7

1167

3027

AQ2

Electrophysiological electroanatomical examination

40.2

307.7

402

102

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

38.3

307.7

958

264

TFP35

NOMESCO Finland

Electroanatomical mapping

29.0

307.7

1304

485

Z3231

NOMESCO Finland

Registered nurse

1.9

305.7

5363

32895

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

11.4

305.2

319

283

B01AB05

ATC

enoxaparin; parenteral

1.9

301.5

6375

41475

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

6.7

300.8

487

747

PH3AC

NOMESCO Finland

Flebography of internal organs with X-ray

54.6

295.8

168

250, ,

Kela drug reimbursment

4.2

292.9

804

1968

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

290.5

5621

35461

C09DX04

ATC

valsartan and sacubitril; oral

6.8

288.9

460

693

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

3.5

281.4

1040

3129

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

279.8

6783

45727

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

5.5

279.0

553

1033

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

6.8

274.1

436

656

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

4.7

267.0

633

1380

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

265.7

7474

52381

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.8

249.2

5492

35686

GD1LA

NOMESCO Finland

4.8

238.1

549

1169

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

238.0

6395

43843

K77

ICPC

Heart failure

3.7

237.2

788

2206

ZXE20

NOMESCO Finland

More than three and less than five hours

2.1

236.1

2830

15032

K84

ICPC

Heart disease other

3.4

236.0

914

2827

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

4.6

235.5

574

1279

R04.0

ICD-10 Finland

Epistaxis

2.3

235.3

1912

8699

SPAT1097

SPAT

Recording of ECG

2.0

233.6

3203

17837

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

4.9

233.1

520

1077

C08DB01

ATC

diltiazem; oral

2.7

229.9

1351

5279

M04AA01

ATC

allopurinol; systemic

1.9

221.3

3248

18474

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

212.7

1461

6150

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

3.2

211.4

891

2898

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.8

210.1

674

1841

FM1CD

NOMESCO Finland

Very extensive CT of heart

15.0

203.2

180

121

M10.9

ICD-10 Finland

Gout, unspecified

2.2

201.4

1885

9066

R02

ICPC

Shortness of breath/dyspnoea

1.9

197.5

2812

15770

WX872

NOMESCO Finland

Intensive care

2.5

197.5

1345

5633

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

4.6

187.6

460

1029

C01BA03

ATC

disopyramide; systemic

7.8

187.6

262

341

E05.89

ICD-10 Finland

Other thyrotoxicosis

13.6

186.8

175

130

AS4

Physiological pacemaker insertion DDD (R)

4.5

179.0

445

1006

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

178.4

5436

37802

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

5.2

174.1

364

712

AC4

MVP

9.5

173.4

206

219

FPD00

NOMESCO Finland

Maze procedure for atrial fibrillation

38.0

171.9

106

Angiography of the heart and coronary arteries

2.2

171.8

1550

7322

G47.3

ICD-10 Finland

Sleep apnoea

1.7

170.2

4244

27960

R4110

NOMESCO Finland

Physiotherapy

1.6

170.1

4960

34025

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

169.6

11952

100800

H03BB01

ATC

carbimazole; oral

3.0

167.9

762

2583

K99

ICPC

Cardiovascular disease other

3.0

166.0

753

2551

C07AB03

ATC

atenolol; systemic

2.3

165.5

1341

6054

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

6.3

161.0

271

432

XF640, ,

NOMESCO Finland

3.0

158.0

711

2397

K83

ICPC

Heart valve disease NOS

4.7

155.9

368

798

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

3.9

154.7

463

1203

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.3

154.0

1248

5628

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.6

154.0

912

3560

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.4

151.7

1110

4787

FFM10

NOMESCO Finland

Occlusion or excision of atrial appendage externally with a closing device

9.9

149.5

172

175

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

9.3

149.4

180

195

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

8.5

149.2

193

229

N02BE01

ATC

paracetamol; systemic, rectal

1.9

147.7

14925

135178

FPD10

NOMESCO Finland

Surgical ablation of atrial fibrillation

20.4

147.1

112

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.4

147.0

1040

4416

C01DA14

ATC

isosorbide mononitrate; oral

1.7

145.4

3514

22818

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

4.0

144.4

412

1034

C01BC03

ATC

propafenone; systemic

11.0

144.1

154

141

FPB10

NOMESCO Finland

Cryoablation of ectopic heart focus

37.2

143.4

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

142.2

2418

14215

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

6.9

141.8

221

325

C01BA01

ATC

quinidine; oral

6.7

140.7

225

340

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.1

138.3

1448

7225

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.4

138.1

518

1565

A02BC02

ATC

pantoprazole; systemic

1.5

137.8

11546

98467

H02AB06

ATC

prednisolone; systemic

1.5

137.6

8046

63671

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

137.3

5211

37628

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.1

136.9

1492

7555

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

135.1

7116

55048

WX002

NOMESCO Finland

Sedation and analgesia

1.6

134.5

3493

23041

J01DB01

ATC

cefalexin; oral

1.6

133.8

13383

118347

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

4.8

132.8

302

635

J01CA04

ATC

amoxicillin; systemic

1.6

130.5

12593

109977

K60

ICPC

Cardiovascular, Result test/procedure

5.5

130.3

255

470

Electrophysiological Special Examination

6.4

130.3

216

339

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

13.7

129.0

120

A46

ICD-10 Finland

Erysipelas

1.7

128.6

3024

19417

A10BK01

ATC

dapagliflozin; oral

1.9

128.1

1715

9325

AA1AD

NOMESCO Finland

CT of head and brain

1.5

127.8

5642

41939

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.7

126.6

703

2653

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

33.4

125.1

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

3.6

124.3

413

1153

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.9

124.1

1830

10262

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

7.8

123.5

172

223

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

3.7

122.8

404

1120

FPD96

NOMESCO Finland

Other operation for atrial fibrillation

18.0

120.4

Catheter ablation of arrhythmia

7.2

120.0

178

248

K29

ICPC

Cardiovascular sympt/complt other

2.2

118.7

1034

4793

SPAT1104

SPAT

Monitoring of emergency patient

2.1

118.6

1266

6350

I49.1

ICD-10 Finland

Atrial premature depolarization

2.5

118.5

779

3192

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.6

118.1

3927

27352

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

7.2

117.9

175

244

R00.2

ICD-10 Finland

Palpitations

2.1

117.3

1181

5795

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

5.0

117.2

252

505

ARB

Catheter ablation of arrhythmia: Cutiing or modification of the AV node

24.5

117.1

A10BK03

ATC

empagliflozin; oral

1.8

116.9

2127

12698

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

9.4

116.3

139

149

ZX120

NOMESCO Finland

Intravenous

1.9

116.1

1676

9326

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

115.4

6097

46742

SPAT1263

SPAT

Sampling

1.5

114.3

6617

51606

205

Kela drug reimbursment

Chronic hypertension

1.5

113.3

5368

40241

FKC20

NOMESCO Finland

Plastic repair of mitral valve leaflet for insufficiency

11.3

112.6

118

105

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

111.7

1289

6645

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

6.8

111.7

175

259

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

110.1

2125

12887

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

109.7

1405

7508

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

2.7

109.6

594

2212

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

5.3

109.4

222

423

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

2.6

109.1

664

2621

K79

ICPC

Paroxysmal tachycardia

6.2

108.8

185

298

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

108.0

3882

27423

TFP43

NOMESCO Finland

Ablation treatment for atrial tachycardia

21.7

107.6

Z50.0

ICD-10 Finland

Cardiac rehabilitation

3.7

107.5

340

918

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.1

106.9

1026

4937

FPB22

NOMESCO Finland

Transvenous radiofrequency ablation of aberrant pathway or focus of heart

9.0

104.3

128

142

FKC60

NOMESCO Finland

Resection and reconstruction of leaflet of mitral valve for insufficiency

9.6

104.3

122

127

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

104.1

4891

36463

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

103.6

1165

5947

Z71.8

ICD-10 Finland

Other specified counselling

1.5

102.8

4994

37452

Z3226

NOMESCO Finland

Physiotherapist

1.6

102.5

2934

19654

WX4

NOMESCO Finland

General anaesthesias

19.8

102.3

AP2

Catheterization of the right side of the heart

7.8

102.2

141

181

TFP40

NOMESCO Finland

Ablation treatment for a-v node re-entry activation

5.0

101.2

217

434

K22

ICPC

Risk factor cardiovascular disease

2.0

99.7

1207

6320

Z94.1

ICD-10 Finland

Heart transplant status

11.0

99.2

106

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

4.7

98.9

228

485

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

98.7

4210

30722

AP3

Catheterization of the right and left side of the heart

8.4

98.4

128

153

FM1GD

NOMESCO Finland

CT of pulmonary arteries and left atrium

29.6

97.9

1CX08, ,

NOMESCO Finland

6.4

97.8

161

251

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

10.4

97.6

108

104

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

97.2

1127

5812

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

95.9

2191

13866

AP1

Catheterization of the left side of the heart

3.1

95.7

405

1316

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.9

95.5

468

1652

A12BA01

ATC

potassium chloride; oral

2.2

94.9

859

4036

M10

ICD-10 Finland

Gout

2.0

94.7

1040

5258

AH3

Treatment of arrhythmias, eg atrial fibrillation, in conjunction with other cardiac surgery

19.0

94.1

3A064, ,

NOMESCO Finland

7.1

92.3

138

194

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.4

91.9

677

2917

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

91.6

2013

12598

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

3.4

91.3

338

1012

R06

ICPC

Nose bleed/epistaxis

2.6

90.6

563

2243

I44.2

ICD-10 Finland

Atrioventricular block, complete

2.4

90.0

659

2832

C08CA01

ATC

amlodipine; oral

1.4

89.0

7322

59893

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

4.9

86.7

192

395

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

86.5

3649

26452

R31

ICD-10 Finland

Unspecified haematuria

1.6

85.7

2194

14252

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.3

85.1

642

2794

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

5.6

85.0

161

288

E06.4

ICD-10 Finland

Drug-induced thyroiditis

37.1

83.6

N02AX02

ATC

tramadol; systemic, rectal

1.4

82.8

7135

58559

S18

ICPC

Laceration/cut

1.4

82.8

8065

67498

R03AC02

ATC

salbutamol; inhalant

1.4

81.9

7864

65619

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.8

81.5

1352

7813

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

8.9

80.9

100

112

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

80.8

2892

20237

M10.0

ICD-10 Finland

Idiopathic gout

2.1

80.4

818

4016

742, ,

NOMESCO Finland

8.6

80.0

102

119

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

5.2

79.9

164

316

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.9

78.2

1044

5638

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

5.1

77.9

164

323

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

77.7

3738

27704

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

5.2

77.4

160

310

A98

ICPC

Health maint/preventive medicine

1.8

77.3

15515

146461

Initial pacemaker installation

5.2

76.3

157

303

AS2

Ventricular pacemaker insertion VVI (R)

4.5

75.9

188

424

R2110

NOMESCO Finland

Giving the first information

2.0

75.4

869

4462

B60

ICPC

Blood and Immunity, Result test/procedure

3.3

74.0

282

860

Q23.11

ICD-10 Finland

Bicuspid aortic valve

4.2

73.9

199

479

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

3.3

72.9

284

878

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.9

72.6

994

5409

C10AA05

ATC

atorvastatin; oral

1.3

72.5

7915

66858

WVA20

NOMESCO Finland

Medicine administration

2.3

72.2

549

2397

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.0

71.5

319

1069

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

4.1

71.3

197

483

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.2

71.0

613

2823

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.1

70.6

669

3195

-60

ICPC

Result test/procedure

1.9

70.1

948

5137

R53

ICD-10 Finland

Malaise and fatigue

1.4

70.0

3769

28417

AB2

AVR bio, stent

4.1

69.8

190

461

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

69.8

1249

7367

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

7.7

68.8

125

T92

ICPC

Gout

2.4

68.7

503

2160

S97

ICPC

Chronic ulcer skin

1.7

68.2

1280

7649

WX740

NOMESCO Finland

Nitrogen oxide therapy

11.1

68.0

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

68.0

10548

93390

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

67.8

1827

11969

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

67.6

2483

17403

Q21.10

ICD-10 Finland

Persistent ostium secundum

7.5

66.9

129

FM1BD

NOMESCO Finland

Extensive CT of heart

6.6

66.9

107

162

WX722

NOMESCO Finland

PEEP

1.9

66.8

860

4583

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

3.8

66.7

207

552

SPAT1325

SPAT

Vaccination

1.3

66.5

5560

44953

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

66.4

654

3170

C03AA03

ATC

hydrochlorothiazide; oral

1.6

66.4

1645

10560

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

4.5

66.0

163

367

A60

ICPC

General and Unspecified, Result test/procedure

2.0

64.5

704

3544

WX419

NOMESCO Finland

Other general anesthesy

3.8

64.3

199

530

WX780

NOMESCO Finland

Remote monitoring CPAP

2.0

64.2

731

3735

7AX01, ,

NOMESCO Finland

28.6

63.9

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

63.1

3850

29571

Initial installation of the atrial pacemaker

7.0

63.0

135

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

62.9

4842

38582

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

62.7

1360

8441

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

6.1

62.2

108

178

XF622

NOMESCO Finland

Measurement of minute volume of heart

5.9

62.2

111

188

I25.2

ICD-10 Finland

Old myocardial infarction

1.7

61.4

1342

8342

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

7.2

61.4

127

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

2.5

61.2

390

1572

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

61.1

1408

8871

WX723

NOMESCO Finland

CPAP therapy

2.0

60.8

702

3605

XF620

NOMESCO Finland

Examination of circulation with color method

6.0

60.7

107

179

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

8.7

60.5

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

5.3

60.1

122

233

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.9

60.0

774

4127

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

59.8

1365

8576

FM1AD

NOMESCO Finland

CT of heart

5.2

59.8

122

234

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.8

59.4

956

5460

I42.8

ICD-10 Finland

Other cardiomyopathies

4.8

59.0

134

282

C08CA02

ATC

felodipine; oral

1.5

58.7

1780

11953

SPAT1260

SPAT

Consultation of another employee

1.4

58.0

2737

20068

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

57.9

2768

20343

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

57.6

7304

62240

L17

ICPC

Foot/toe symptom/complaint

1.3

57.4

4731

37969

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

7.6

56.9

105

AH2

Treatment of atrial fibrillation by maze surgery or its modification as the only procedure

22.1

56.8

J01FF01

ATC

clindamycin; systemic

1.4

56.6

4009

31437

I45.9

ICD-10 Finland

Conduction disorder, unspecified

3.3

56.5

210

631

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

56.5

1203

7424

A91

ICPC

Abnormal result investigation NOS

1.8

56.5

891

5059

AC2

MVR bio

10.7

56.3

I20.09

ICD-10 Finland

Unstable angina

1.7

56.1

1124

6824

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

55.7

759

4118

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.7

55.6

303

1132

C10AA01

ATC

simvastatin; oral

1.3

55.2

7897

68210

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

12.9

55.1

A08

ICPC

Swelling

1.7

55.0

1029

6132

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

54.9

5374

44133

FP1E5

NOMESCO Finland

ECG, with computer analysis

77.7

54.9

AA1

Conventional CABG

2.3

54.8

431

1909

Catheterization and pressure measurement of the right side of the heart

5.2

54.6

112

216

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

4.3

54.6

140

325

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.9

54.5

673

3535

P06

ICPC

Sleep disturbance

1.5

53.8

1616

10817

R05

ICPC

Cough

1.4

53.6

3521

27254

M01AE01

ATC

ibuprofen; systemic, rectal

0.8

53.3

11801

126685

SPAT1255

SPAT

Intravenous administration of medicine

1.7

52.9

1144

7084

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

52.6

5935

49608

A11

ICPC

Chest pain NOS

1.6

52.3

1463

9636

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

52.2

2152

15364

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

51.5

2055

14577

TFP33

NOMESCO Finland

Simple electrophysiological investigation (e.g. ventricular stimulation)

10.4

51.5

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

5.5

51.4

177

UJF32

NOMESCO Finland

Coloscopy

1.3

51.3

4350

34937

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

51.2

1417

9310

XF409

NOMESCO Finland

Other special ECG

4.0

50.9

144

360

I34.8

ICD-10 Finland

Other nonrheumatic mitral valve disorders

6.9

50.9

113

FPJ02

NOMESCO Finland

Revision of ventricular pacemaker generator

5.8

50.4

156

FPE24

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, ventricular electrodes, CRT-P (VVIR)

8.4

50.4

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

3.7

50.1

162

445

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

50.1

859

4995

FPG04

NOMESCO Finland

Insertion of internal defibrillator, atrial and chamber electrode

15.3

49.2

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

49.1

828

4791

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.2

49.0

403

1819

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

6.7

48.4

113

SPAT1281

SPAT

Other administrative function

1.6

48.3

1145

7249

I97.0

ICD-10 Finland

Postcardiotomy syndrome

4.6

48.3

114

248

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

48.2

819

4748

FKC96

NOMESCO Finland

Other repair of mitral valve for insufficiency

6.6

48.0

117

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

48.0

773

4412

A04

ICPC

Weakness/tiredness general

1.4

47.9

2330

17118

R60.0

ICD-10 Finland

Localized oedema

1.4

47.8

2148

15561

TFC20

NOMESCO Finland

Catheterisation of both sides of heart

7.8

47.8

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

2.5

47.6

291

1151

R50.9

ICD-10 Finland

Fever, unspecified

1.4

47.3

2282

16739

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.8

47.3

737

4166

K07

ICPC

Swollen ankles/oedema

1.7

47.2

894

5342

2BD01, ,

NOMESCO Finland

6.9

47.1

104

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

46.7

2030

14615

J01AA02

ATC

doxycycline; systemic

1.3

46.6

11911

109468

J01FA06

ATC

roxithromycin; oral

1.3

46.5

5496

46005

SPAT1081

SPAT

Cardiorespiratory global assessment

1.7

46.2

967

5932

C09AA04

ATC

perindopril; oral

1.7

46.0

903

5449

FL1AC

NOMESCO Finland

Left cardioangiography

2.3

45.6

346

1510

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

2.4

45.6

313

1307

3AC01, ,

NOMESCO Finland

3.2

45.2

181

570

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

4.7

45.1

103

218

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.8

45.0

661

3669

R04.2

ICD-10 Finland

Haemoptysis

1.8

45.0

647

3569

FFM30

NOMESCO Finland

Occlusion of atrial appendage internally by internal suture ligation

13.5

44.9

A29

ICPC

General symptom/complaint other

1.4

44.4

2155

15812

SPAT1353

SPAT

Intensive monitoring

3.9

43.9

129

332

E66.8

ICD-10 Finland

Other obesity

1.9

43.7

580

3118

SPAT1251

SPAT

Organisation of medication

1.9

43.7

550

2907

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.8

43.6

652

3640

B01AB04

ATC

dalteparin; parenteral

1.7

43.5

805

4780

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.5

43.4

1327

8898

N05CF01

ATC

zopiclone; oral

1.3

43.4

4903

40724

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

43.0

2290

17060

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

3.8

42.6

131

348

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

42.4

5061

42298

FPE36

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with ventricular electrodes

8.6

42.4

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

42.3

3159

24804

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

42.0

2014

14736

TK800

NOMESCO Finland

Hemodialysis

2.1

41.7

386

1827

AD1

TVP

8.8

41.7

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

6.2

41.7

115

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

41.4

2023

14847

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.7

41.2

859

5263

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

9.1

41.0

XF602

NOMESCO Finland

Bloodpressure monitoring

2.6

41.0

232

884

C09CA01

ATC

losartan; oral

1.3

41.0

4348

35772

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

40.9

1203

7998

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

7.1

40.8

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

4.8

40.8

189

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

14.2

40.6

J01MA12

ATC

levofloxacin; systemic

1.3

40.4

3015

23650

AP4

Myocardial biopsy

8.1

40.3

-69

ICPC

Other reason for encounter NEC

1.8

40.2

572

3144

XX9XB

NOMESCO Finland

Other X-ray examination with contrast

4.7

40.1

192

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

40.0

2709

20947

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

3.2

39.5

153

473

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

39.1

9361

84378

A99

ICPC

Disease/condition unspecnature/site

1.4

39.1

1573

11141

SPAT1254

SPAT

Administration of medicine

1.4

39.0

2304

17434

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.6

39.0

925

5851

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.6

39.0

868

5406

-34

ICPC

Blood test

2.0

38.9

411

2045

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

5.1

38.8

159

74642

ICD-8 Finland

Congenital anomalies of heart, Defectus septi atriorum, ostium secundum

8.9

38.7

I45.6

ICD-10 Finland

Pre-excitation syndrome

4.2

38.1

100

237

A97

ICPC

No disease

1.3

37.9

2950

23251

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

37.9

2344

17860

AC1

MVR mechanical

11.5

37.6

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.4

37.6

1519

10761

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

37.6

4318

35803

127

Kela drug reimbursment

Transplant complication

2.5

37.6

246

1006

U06

ICPC

Haematuria

1.9

37.4

497

2673

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

37.3

3552

28760

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

37.3

1056

6958

I47.0

ICD-10 Finland

Re-entry ventricular arrhythmia

5.3

37.2

139

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.6

37.1

208

790

ZXA10

NOMESCO Finland

Bilateral

1.3

37.0

2779

21786

C09CA03

ATC

valsartan; oral

1.4

36.9

1572

11248

M79.6

ICD-10 Finland

Pain in limb

1.2

36.6

6181

53520

C07AG02

ATC

carvedilol; oral

1.6

36.6

1019

6690

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

36.4

1842

13578

SPAT1310

SPAT

Counselling related to known health issue

1.3

36.4

4538

37965

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

36.3

2342

17950

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

2.2

36.3

313

1442

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

36.2

781

4826

WZC30

NOMESCO Finland

Teaching

1.3

36.2

2584

20104

N19

ICD-10 Finland

Unspecified kidney failure

1.7

36.1

691

4137

C09AA02

ATC

enalapril; systemic

1.3

36.1

3314

26690

WX730

NOMESCO Finland

Conventional respirator

2.3

36.0

277

1217

R42

ICD-10 Finland

Dizziness and giddiness

1.3

36.0

3639

29672

PD5AD

NOMESCO Finland

CT of aorta

1.9

35.9

472

2530

ATX

Other pacemaker replacement or related action, such as cord removal or replacement

5.3

35.8

133

K28

ICPC

Limited function/disability (K)

1.9

35.7

423

2192

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

35.6

3509

28511

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.8

35.6

601

3476

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

35.6

884

5652

I42.5

ICD-10 Finland

Other restrictive cardiomyopathy

9.1

35.5

AS7

Arrhythmia pacemaker insertion VVI (R) S

5.0

35.5

149

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.5

35.4

1299

9033

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.1

35.3

337

1615

K92.1

ICD-10 Finland

Melaena

1.6

35.3

950

6189

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

35.2

4541

38111

H26.4

ICD-10 Finland

After-cataract

1.4

35.1

1785

13163

Mitral valve plasty

7.7

35.1

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

2.2

34.8

283

1273

-50

ICPC

Medication/prescr/renewal

1.7

34.7

607

3547

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.8

34.5

576

3322

ZXA00

NOMESCO Finland

Right side

1.3

34.3

4024

33377

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

10.0

34.3

K34

ICPC

Cardiovascular, Blood test

4.4

34.3

197

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

34.2

4022

33373

R55

ICD-10 Finland

Syncope and collapse

1.4

34.0

1849

13783

J01FA10

ATC

azithromycin; systemic

1.2

33.8

6995

61698

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.9

33.6

459

2491

M01AX05

ATC

glucosamine; oral

1.3

33.6

3076

24732

-44

ICPC

Preventive immunization/medic

1.5

33.5

1250

8714

Q21.19

ICD-10 Finland

Atrial septal defect NOS

5.4

33.5

123

Q21.09

ICD-10 Finland

Ventricular septal defect NOS

8.0

33.5

SPAT1252

SPAT

Overall medication plan or its review

1.5

33.5

1108

7544

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

33.5

5051

43090

TFJ02

NOMESCO Finland

Muscle biopsy of heart

5.8

33.3

103

FFC00

NOMESCO Finland

Suture of ostium secundum type ASD

9.5

33.1

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

33.1

7459

66309

E66.9

ICD-10 Finland

Obesity, unspecified

1.9

33.1

408

2143

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

32.8

1101

7516

Coronary artery bypass surgery

1.9

32.7

400

2094

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

32.7

601

3559

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

32.6

9756

89127

K87

ICPC

Hypertension complicated

1.8

32.2

467

2583

AR3

Catheter ablation of arrhythmia, target: atrial tachycardia

12.9

32.1

T82

ICPC

Obesity

1.9

32.0

410

2181

Q87.4

ICD-10 Finland

Marfan syndrome

9.7

31.9

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

1.6

31.8

721

4509

R07.3

ICD-10 Finland

Other chest pain

1.4

31.7

1506

10969

WVA50

NOMESCO Finland

Pharmacological cardioversion

34.1

31.7

L28

ICPC

Limited function/disability (L)

1.3

31.7

3184

25878

J01CF05

ATC

flucloxacillin; systemic

1.5

31.7

965

6457

FCA50

NOMESCO Finland

Resection and reconstruction of ascending aorta using tube graft

3.7

31.5

100

272

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

4.1

31.5

210

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1.7

31.5

613

3687

L04AD02

ATC

tacrolimus; systemic

2.8

31.4

153

541

C07AB04

ATC

acebutolol; systemic

2.1

31.2

283

1330

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.5

31.1

189

747

C08CA13

ATC

lercanidipine; oral

1.3

31.1

2433

19133

FC1BC

NOMESCO Finland

Extensive angiography of thoracal aortta

4.8

31.1

143

Mitral valve Replacement (MVR)

9.0

31.1

M54.5

ICD-10 Finland

Low back pain

1.2

31.0

4820

41170

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

31.0

1243

8784

WX720

NOMESCO Finland

Own respiration

1.6

30.9

727

4587

L15

ICPC

Knee symptom/complaint

1.3

30.9

3482

28686

I20.00

ICD-10 Finland

Unstable angina

1.7

30.8

520

3008

K48

ICPC

Cardiovascular, Clarification/discussion RFE/demand

3.4

30.7

108

315

SPAT1336

SPAT

Request for examination

1.8

30.6

506

2911

D68.3

ICD-10 Finland

Haemorrhagic disorder due to circulating anticoagulants

3.6

30.6

100

278

J01DA01

ATC

[U] cefalexin

1.2

30.5

8667

78533

FPB32

NOMESCO Finland

Transvenous radiofrequency ablation of pulmonary vein pathway or focus

35.4

30.5

N06AX11

ATC

mirtazapine; oral

1.2

30.4

4642

39560

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

30.4

2150

16668

T90

ICPC

Diabetes non-insulin dependent

1.2

30.3

4237

35762

ZXA05

NOMESCO Finland

Left side

1.3

30.3

3709

30846

FK1BT

NOMESCO Finland

Implantation of cardiac pacemaker with X-ray guidance

3.8

30.2

239

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

8.2

30.2

F1279, ,

NOMESCO Finland

9.7

30.2

A02BC05

ATC

esomeprazole; systemic

1.2

30.2

5801

50611

K02.1

ICD-10 Finland

Caries of dentine

1.2

30.0

7705

69105

FFM32

NOMESCO Finland

Occlusion or excision of atrial appendage transvenously with a closing device

5.7

30.0

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

6.0

30.0

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

29.9

1623

12084

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

29.8

1239

8812

S16

ICPC

Bruise/contusion

1.8

29.8

476

2712

S29

ICPC

Skin symptom/complaint other

1.3

29.7

3010

24469

R03BA02

ATC

budesonide; inhalant

1.3

29.6

2197

17140

A10

ICPC

Bleeding/haemorrhage NOS

2.6

29.3

163

617

FPJ23

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with ventricular electrodes

9.7

29.3

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

29.2

2048

15847

AB1

AVR mechanical

3.7

29.1

241

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.5

29.0

1047

7250

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

28.9

5261

45591

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

1.6

28.8

609

3744

ECB00

NOMESCO Finland

Suture of gingiva

1.7

28.8

530

3142

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.5

28.8

800

5247

L04AA06

ATC

mycophenolic acid; systemic

2.1

28.8

271

1294

I71.00

ICD-10 Finland

Dissecting aneurysm of aorta (ruptured) [any part]

3.4

28.6

102

300

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

2.9

28.6

136

475

FM1EE, ,

SPAT

2.2

28.4

234

1059

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

28.4

3817

32038

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.6

28.3

695

4430

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

28.3

1459

10769

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

1.9

28.2

381

2062

I49

ICD-10 Finland

Other cardiac arrhythmias

2.3

28.2

210

912

Z01.7

ICD-10 Finland

Laboratory examination

1.3

28.1

2231

17562

I31.3

ICD-10 Finland

Pericardial effusion (noninflammatory)

4.0

28.0

194

SPAT1301

SPAT

No procedures

1.2

27.9

4672

40119

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.7

27.8

528

3157

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.7

27.7

463

2673

B80

ICPC

Iron deficiency anaemia

1.9

27.7

346

1827

SPAT1079

SPAT

Echocardiography

2.3

27.6

215

951

WX703

NOMESCO Finland

Insertion of pharyngeal or nasopharyngeal tube

8.9

27.6

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

27.6

548

3316

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

3.3

27.5

103

313

TFN04, ,

NOMESCO Finland

3.2

27.2

107

335

FFW96

NOMESCO Finland

Other operation on atria

5.2

27.0

106

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

1.8

27.0

396

2200

L04

ICPC

Chest symptom/complaint

1.5

26.9

840

5647

SPAT1312

SPAT

General health counselling

1.2

26.6

4197

35783

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

6.7

26.6

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

26.4

1668

12703

S21

ICPC

Skin texture symptom/complaint

1.3

26.3

2233

17719

SPAT1377

SPAT

Polysomnography

1.8

26.3

428

2451

ASB

Insertion of a biventricular physiological pacemaker DDD (R)

5.9

26.3

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

26.3

5063

44026

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.8

26.2

428

2455

74639

ICD-8 Finland

Congenital anomalies of heart, Defectus septi ventriculorum

8.7

26.1

C09CA06

ATC

candesartan; oral

1.2

26.1

3395

28349

GE1BE

NOMESCO Finland

Mediastinal ultrasound examinaiton through oesophagus

5.1

26.0

106

W0X00, ,

SPAT

5.0

25.9

110

ZX108

NOMESCO Finland

Inhalation

2.8

25.9

128

457

Z2446

NOMESCO Finland

Social worker

1.5

25.8

746

4934

FPG42

NOMESCO Finland

Replacement of electrode(s) in transvenous cardioverter-defibrillator

8.9

25.8

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

1.7

25.5

462

2727

K50

ICPC

Cardiovascular, Medication/prescr/renewal

3.4

25.5

273

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

2.8

25.5

127

455

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

25.4

1925

15042

ZXD00

NOMESCO Finland

Emergency procedure

1.7

25.4

426

2463

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

2.2

25.2

205

925

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

25.2

774

5188

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.6

25.1

547

3388

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

25.0

1354

10069

Catheterization and pressure measurement of the left side of the heart

1.9

24.8

288

1485

A10BH05

ATC

linagliptin; oral

1.5

24.7

896

6207

A62

ICPC

General and Unspecified, Administrative procedure

1.8

24.6

347

1904

M01AH05

ATC

etoricoxib; oral

0.8

24.6

7161

78423

PC1BD

NOMESCO Finland

Extensive CT of thoracic aorta

3.1

24.6

103

335

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.5

24.6

719

4767

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

24.5

1206

8827

S76

ICPC

Skin infection other

1.5

24.4

789

5345

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

1.8

24.3

336

1834

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

24.3

613

3934

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.5

24.3

913

6370

M25.0

ICD-10 Finland

Haemarthrosis

2.3

24.2

187

825

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

24.1

6281

56011

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

24.1

5598

49417

AR2

Catheter ablation of arrhythmia, target: extra pathway (WPW, AVRT, PJRT)

6.5

24.1

A03

ICPC

Fever

1.3

24.1

1795

13986

U02

ICPC

Urinary frequency/urgency

1.3

24.1

1899

14912

FKE60

NOMESCO Finland

Repair of mitral valve regurgitation with transvenously implanted clip

7.5

24.1

H02AB07

ATC

prednisone; oral

1.3

24.0

1824

14252

J01MA02

ATC

ciprofloxacin; systemic

1.2

24.0

6102

54302

J45.1

ICD-10 Finland

Nonallergic asthma

1.4

24.0

930

6526

S80.0

ICD-10 Finland

Contusion of knee

1.5

23.9

809

5527

SFA20

NOMESCO Finland

Two-surface restoration

1.2

23.9

7523

68169

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

0.4

23.9

2684

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.3

23.8

1474

11182

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

23.8

8582

78639

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.9

23.7

305

1626

I36.0

ICD-10 Finland

Nonrheumatic tricuspid (valve) stenosis

6.9

23.6

XF405

NOMESCO Finland

Symptom ECG

2.8

23.5

119

430

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

23.5

2181

17487

XFP02, ,

NOMESCO Finland

5.5

23.5

R4120

NOMESCO Finland

Occupational therapy

1.5

23.4

850

5890

R05

ICD-10 Finland

Cough

1.2

23.4

2887

23936

WX882

NOMESCO Finland

High dependency care

1.7

23.3

426

2521

-62

ICPC

Administrative procedure

1.8

23.3

366

2077

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.4

23.2

1049

7564

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.1

23.1

232

1136

AR1

Catheter ablation of arrhythmia, target: AV node reentry activation (AVNRT)

4.0

23.1

163

TK810

NOMESCO Finland

Hemofiltration

2.8

23.1

118

429

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

23.1

815

5618

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

1.8

22.9

370

2116

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

1.8

22.9

332

1840

ZXE90

NOMESCO Finland

More than 22 hours

2.7

22.9

124

465

R03BB04

ATC

tiotropium bromide; inhalant

1.3

22.7

1610

12453

C02AC05

ATC

moxonidine; oral

1.5

22.6

746

5072

SPAT1153

SPAT

Removal of sutures

1.2

22.6

4835

42311

288

Kela drug reimbursment

Febuxostat

3.1

22.6

310

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

2.7

22.6

119

440

M04AA03

ATC

febuxostat; oral

3.1

22.5

290

3A149, ,

NOMESCO Finland

9.3

22.5

D07AC01

ATC

betamethasone; topical

1.2

22.5

5180

45626

UKC02

NOMESCO Finland

Cystoscopy

1.2

22.5

2839

23585

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.6

22.5

327

5646

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

22.5

1863

14721

FPH00

NOMESCO Finland

Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator

6.5

22.4

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.4

22.3

151

630

WX890

NOMESCO Finland

Intesive care monitoring

2.6

22.3

125

477

DKW00

NOMESCO Finland

Cauterisation of mucosa of nose

2.2

22.3

178

798

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

22.2

4638

40489

E0000UV, ,

ATC

1.2

22.1

5588

49592

I95.9

ICD-10 Finland

Hypotension, unspecified

1.9

22.1

263

1367

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

22.1

423

2535

C10AX09

ATC

ezetimibe; oral

1.2

22.0

2770

22999

B01AB10

ATC

tinzaparin; parenteral

1.3

22.0

1521

11725

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

1.7

22.0

369

2135

GD1AD

NOMESCO Finland

Thorax CT examination

1.4

22.0

1021

7399

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.6

21.9

456

2793

R29

ICPC

Respiratory symptom/complaint other

1.4

21.9

848

5947

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

3.4

21.9

230

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

1.9

21.9

288

1548

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.4

21.9

1241

9289

L03

ICPC

Low back symptom/complaint

1.2

21.8

3720

31851

FM1DM

NOMESCO Finland

Heart very extensive MRI examination with 3 Tesla magnet

6.5

21.6

349

Kela drug reimbursment

Febuxostat

3.2

21.6

257

N17

ICPC

Vertigo/dizziness

1.3

21.5

1842

14607

FP2H5

NOMESCO Finland

ECG, telemetry

5.1

21.5

FPJ21

NOMESCO Finland

Revision of cardioverter-defibrillator with ventricular electrode

5.1

21.5

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

1.6

21.4

541

3474

WX320

NOMESCO Finland

Spinalanesthesy

1.2

21.4

3658

31323

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

21.3

3730

32005

K24

ICPC

Fear of heart disease

1.7

21.3

385

2273

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.4

21.3

909

6489

N05BA04

ATC

oxazepam; oral

1.2

21.3

3374

28678

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.7

21.2

418

2526

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

1.5

21.2

789

5494

SFA10

NOMESCO Finland

One-surface restoration

1.2

21.1

7153

64954

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.3

21.0

1303

9887

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.3

21.0

1849

14719

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.4

20.9

797

5573

5AB14, ,

NOMESCO Finland

5.5

20.9

I20.8

ICD-10 Finland

Other forms of angina pectoris

2.4

20.8

146

619

I20.01

ICD-10 Finland

Unstable angina

1.6

20.8

509

3244

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

1.7

20.8

372

2191

3A422, ,

NOMESCO Finland

6.6

20.7

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

1.9

20.7

255

1342

FGE10

NOMESCO Finland

Replacement of tricuspid valve using biological prosthesis

21.4

20.7

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

20.7

767

5335

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

20.7

2898

24315

I34

ICD-10 Finland

Nonrheumatic mitral valve disorders

5.2

20.6

R01AD09

ATC

mometasone; nasal

1.2

20.6

5396

47960

-42

ICPC

Electrical tracing

2.0

20.6

219

1097

QXB99, ,

SPAT

1.7

20.5

408

2471

T14.5

ICD-10 Finland

Injury of blood vessel(s) of unspecified body region

2.7

20.4

112

423

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.7

20.3

396

2388

B82

ICPC

Anaemia other/unspecified

1.6

20.2

449

2796

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

20.2

2434

20090

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

20.2

5807

51990

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

20.2

5738

51323

UJF92

NOMESCO Finland

Capsular endoscopy

1.9

20.1

260

1390

FN1AD

NOMESCO Finland

CT of coronary arteries

2.0

20.1

229

1175

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

20.1

2041

16526

FXG00

NOMESCO Finland

Insertion and use of IABP

3.9

20.1

153

R00.8

ICD-10 Finland

Other and unspecified abnormalities of heart beat

2.1

20.0

181

853

S06.0

ICD-10 Finland

Concussion

1.3

20.0

1365

10496

I33.9

ICD-10 Finland

Acute endocarditis, unspecified

4.3

20.0

119

A02BC01

ATC

omeprazole; systemic

1.2

20.0

3859

33388

SFA30

NOMESCO Finland

Three-surface restoration

1.2

20.0

5649

50492

Aortic Valve Replacement (AVR)

4.4

19.9

111

C07BB07

ATC

bisoprolol and thiazides; systemic

1.5

19.9

555

3644

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3002032) Base excess in Venous blood by calculation

3530

18417

2.15

318.57

4.5

4.0

1.70

1.73

mmol/l

0.20

3245

16074

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4795

26811

2.10

307.65

3.2

2.7

20.91

22.15

8.64

4493

24776

(3013826) Glucose [Moles/volume] in Serum or Plasma

12707

95924

2.32

307.65

7.9

5.5

6.72

6.90

mmol/l

22.59

12368

91842

(3019230) Fractional oxyhemoglobin in Venous blood

1324

3529

3.98

307.65

3.5

2.7

61.78

61.59

0.10

1318

3513

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2523

10418

2.66

307.65

4.2

4.1

24.30

24.10

mmol/l

2.78

2490

10285

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4984

28837

2.03

307.65

3.2

2.7

2.35

2.25

g/l

32.65

4648

26521

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2103

7133

3.22

307.65

4.1

3.3

4.22

4.42

pmol/l

15.22

1955

6283

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3417

14853

2.62

307.65

4.1

3.1

323.10

213.13

ng/l

30.58

3197

13709

(3027456) Digoxin [Moles/volume] in Serum or Plasma

2624

3245

9.37

307.65

3.4

3.2

0.79

0.81

nmol/l

1.07

2223

2543

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10558

56640

3.32

307.65

5.3

3.2

2039.18

1571.66

ng/l

24.67

9802

49376

(3032080) INR in Blood by Coagulation assay

13719

81142

4.77

307.65

44.0

15.7

1.74

1.28

inr

307.65

12464

67897

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3635

18909

2.17

307.65

4.4

4.0

5.84

5.80

kpa

1.70

3556

18488

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

5826

33636

2.11

307.65

5.7

4.3

405.80

515.74

ng/l

1.37

5371

28778

(3012544) pH of Venous blood

3671

19240

2.16

307.65

4.5

4.0

7.38

0.22

1847

11456

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2608

11763

2.43

307.65

10.8

8.0

24.92

24.71

mmol/l

2.02

2595

11673

(3022948) Iron [Moles/volume] in Serum or Plasma

5212

30634

2.01

307.65

3.2

2.7

12.16

12.37

umol/l

1.31

4895

28357

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

13112

105267

2.11

307.65

5.2

4.1

15.52

15.01

pmol/l

91.96

12176

94704

(3024928) Oxygen saturation in Venous blood

1416

4326

3.47

307.65

3.6

3.1

61.44

60.92

0.36

1385

4147

(3000991) Gas panel - Venous blood

3348

16026

2.35

307.65

11.5

8.9

—

(3024354) Oxygen [Partial pressure] in Venous blood

3160

15644

2.25

307.65

3.8

3.2

4.48

kpa

0.05

3084

15234

(3044889) 12 lead EKG panel

13282

105174

2.25

307.65

8.2

4.5

1206.74

2683.36

0.37

277

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

9969

64708

2.32

307.65

6.2

4.2

42.70

84.35

ng/l

3.09

8312

50917

(3014111) Lactate [Moles/volume] in Serum or Plasma

3468

16747

2.34

307.65

10.3

7.4

1.35

1.37

mmol/l

0.45

3387

16418

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1709

6529

2.79

307.01

3.9

2.9

0.36

0.35

iu/ml

0.49

1035

3547

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4905

29199

1.95

305.79

4.4

3.4

0.82

0.81

mmol/l

0.95

4640

27346

(3021589) Normoblasts [#/volume] in Blood

9128

66244

1.82

301.62

16.7

12.8

0.00

e9/l

0.19

7551

53859

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2213

9731

2.46

297.94

3.4

2.9

1.10

1.21

7.38

2204

9691

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

10934

85350

1.80

267.18

7.4

7.0

14.49

12.26

umol/l

51.47

10506

81469

(3004119) Hemoglobin [Mass/volume] in Venous blood

2424

11604

2.27

266.64

4.0

3.4

135.46

127.52

g/l

49.18

2373

11263

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

10025

76742

1.75

257.31

9.2

7.0

1.19

1.21

mmol/l

65.13

9498

70625

(3018677) aPTT in Platelet poor plasma by Coagulation assay

4502

27412

1.87

253.49

3.0

2.0

32.44

29.66

110.01

4383

26675

(3020779) Urea [Moles/volume] in Serum or Plasma

3186

17430

2.02

245.85

9.5

7.2

11.08

10.91

mmol/l

0.57

3055

16584

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

10801

85381

1.73

237.53

9.7

7.8

1.20

1.21

mmol/l

68.78

9311

73485

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3106

17172

1.99

231.08

4.5

3.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

14745

128836

2.17

229.69

6.7

5.2

2.09

2.02

mu/l

7.59

13842

116839

(3023368) Bacteria identified in Blood by Culture

7229

51700

1.69

227.11

5.5

4.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8584

64671

1.66

217.45

3.8

3.1

162.93

167.24

ug/l

0.59

7918

59243

(36304419) Bacteria [Presence] in Urine

6493

45666

1.68

213.33

3.9

3.5

1189.75

250.38

estimate

0.38

245

(3030467) Casts [#/volume] in Urine by Automated count

6827

48904

1.66

207.24

3.9

3.6

0.57

0.45

e6/l

2.64

5266

36637

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

15566

140213

2.49

206.33

27.9

19.4

25.67

27.97

mg/l

16.82

14232

118857

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2871

16018

1.95

205.55

2.9

2.4

12.16

7.29

ug/l

11.98

2631

13957

(3013512) EKG study

7896

59051

1.63

199.32

6.6

3.9

0.67

0.76

—

172

(3002582) Erythrocytes [#/volume] in Urine

7621

56507

1.63

199.13

4.0

3.7

116.19

98.30

e6/l

0.34

6014

43866

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

13724

118518

1.85

197.82

10.1

8.9

81.60

81.55

u/l

0.04

13176

112378

(3013650) Neutrophils [#/volume] in Blood by Automated count

10723

86883

1.64

192.01

9.4

9.9

4.40

4.34

e9/l

1.97

9126

74849

(3018095) Leukocytes [#/volume] in Urine

8123

61591

1.61

190.62

4.8

4.3

89.95

114.07

e6/l

2.09

6178

45016

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

6282

44776

1.64

189.63

2.9

2.4

3.19

2.90

mg/l

14.22

5559

38343

(3018418) pH of Serum or Plasma

6975

51136

1.62

186.96

5.0

4.6

7.40

0.41

5300

36826

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

13117

112403

1.75

185.78

35.6

23.8

14.14

13.84

96.07

13032

110878

(3001604) Monocytes [#/volume] in Blood

9768

77796

1.60

183.56

6.9

6.3

0.64

0.63

e9/l

6.34

8261

65805

(3006315) Basophils [#/volume] in Blood

9789

78106

1.60

181.63

6.9

6.3

0.04

e9/l

1.30

8286

66119

(3019069) Monocytes/Leukocytes in Blood

9171

72090

1.59

181.04

7.3

6.7

9.45

9.18

13.83

8635

67287

(3033658) Prothrombin time (PT) actual/Normal

5825

41100

1.63

180.92

5.6

4.4

65.88

86.21

307.65

5727

40303

(3013115) Eosinophils [#/volume] in Blood

9981

80090

1.60

180.07

7.2

6.5

0.19

0.20

e9/l

14.34

8624

68839

(3003396) Base excess in Arterial blood by calculation

3624

22560

1.77

179.98

10.5

7.4

0.77

0.93

mmol/l

1.54

3056

18641

(3006504) Eosinophils/Leukocytes in Blood

9140

71865

1.59

179.60

7.3

6.6

2.68

2.87

14.22

8608

67076

(3027801) Oxygen [Partial pressure] in Arterial blood

3638

22719

1.76

178.49

10.6

7.5

11.67

12.06

kpa

4.53

3488

21846

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3639

22734

1.76

178.27

10.6

7.5

5.02

5.08

kpa

3.33

3493

21871

(3019977) pH of Arterial blood

3636

22727

1.76

177.73

10.6

7.5

7.42

2.05

1801

12539

(3022096) Basophils/Leukocytes in Blood

9135

71916

1.59

177.72

7.3

6.7

0.64

0.66

2.05

8615

67146

(3019198) Lymphocytes [#/volume] in Blood

9886

79343

1.59

176.48

7.0

6.4

1.76

1.89

e9/l

8.10

8571

68751

(3002030) Lymphocytes/Leukocytes in Blood

9258

73197

1.58

176.11

7.3

6.6

24.34

26.05

40.44

8773

69100

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6678

49032

1.59

174.04

3.4

35.49

36.14

u/l

0.28

6280

45900

(3000850) Epithelial cells [#/volume] in Urine

5609

39590

1.62

171.76

3.1

2.9

4.38

4.41

e6/l

0.09

5138

36141

(3016502) Oxygen saturation in Arterial blood

3314

20459

1.77

167.89

11.0

7.7

94.60

95.44

6.74

3220

19756

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2161

11670

1.97

167.36

13.6

9.1

24.23

24.25

mmol/l

0.06

2086

11401

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3462

21798

1.74

163.01

2.0

1.9

—

(3018010) Neutrophils/Leukocytes in Blood

9012

71692

1.55

159.88

7.2

6.5

60.07

58.48

30.32

8663

68214

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3643

23514

1.70

155.66

2.0

1.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4568

31330

1.62

153.62

2.1

2.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3050

18815

1.75

153.27

11.8

8.2

122.49

120.90

g/l

3.79

2997

18387

(3026782) Osmolality of Urine

4844

33715

1.61

153.26

3.4

3.2

526.74

542.55

mosm/kgh2o

6.26

4305

29656

(3026493) Urate [Moles/volume] in Serum or Plasma

6009

44250

1.55

147.56

3.6

3.0

386.58

359.67

umol/l

62.52

5237

38340

(40761511) CBC panel - Blood by Automated count

15449

141630

2.11

147.23

25.6

17.3

—

110.22

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2236

12772

1.86

144.54

13.9

9.4

92.74

93.91

7.79

2224

12736

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2166

12330

1.86

141.30

14.2

9.5

0.57

0.63

12.38

2157

12259

(3024561) Albumin [Mass/volume] in Serum or Plasma

9352

76173

1.51

139.96

5.6

5.4

34.46

34.87

g/l

9.84

8794

71137

(40758558) Short blood count panel - Blood

6165

46158

1.52

137.63

7.2

6.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

15777

146365

2.27

136.77

37.8

23.5

139.60

mmol/l

0.02

15661

143638

(3027945) Reticulocytes/Erythrocytes in Blood

3497

23034

1.65

135.59

2.5

1.86

1.77

5.51

3138

20402

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2201

12784

1.82

134.06

13.9

9.2

1.25

1.32

4.25

2189

12704

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3450

22746

1.64

132.91

4.9

4.4

259.86

245.22

u/l

5.12

3289

21573

(3052851) Hemolysis interference index of Serum or Plasma

1030

4552

2.34

132.73

3.8

3.6

2.01

2.07

index

0.09

602

2309

(3023103) Potassium [Moles/volume] in Serum or Plasma

15778

146587

2.24

132.73

38.3

23.7

4.04

4.01

mmol/l

48.55

15650

143679

(3031040) Bacteria [#/volume] in Urine by Automated count

11779

101254

1.54

132.20

5.8

5.2

1013.59

1760.63

e6/l

1.37

227

1595

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

227

384

5.96

127.03

5.7

6.3

74.95

68.08

3.21

201

290

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

14874

135809

1.81

125.89

29.9

19.2

71.75

74.92

ml/min/173m2

74.19

14460

126904

(3042936) Bacteria identified in Isolate by Culture

3615

24640

1.59

119.69

2.4

2.1

—

(40767503) Oxygen content in Capillary blood by calculation

888

3849

2.37

119.37

2.9

2.7

16.53

16.18

2.56

874

3760

(3010421) pH of Blood

1141

5496

2.15

118.91

4.3

3.9

7.42

7.41

2.33

1130

5416

(3027315) Oxygen [Partial pressure] in Blood

853

3669

2.39

116.63

4.6

4.3

8.38

8.45

kpa

0.63

841

3580

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

991

4547

2.25

116.53

3.5

2.3

3.59

3.63

g/l

0.31

955

4362

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

6842

53657

1.46

114.99

2.5

2.3

213.09

231.68

u/l

1.04

6465

50573

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1915

11162

1.80

114.03

14.6

9.6

16.04

16.00

0.22

1867

10788

(3013290) Carbon dioxide [Partial pressure] in Blood

844

3650

2.37

113.95

4.6

4.3

4.94

4.99

kpa

1.18

832

3562

(3012501) Base excess in Blood by calculation

843

3649

2.37

113.58

4.6

4.3

2.51

2.61

mmol/l

0.42

599

2499

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3520

24151

1.57

112.25

6.9

6.2

1.05

1.03

mmol/l

3.18

3296

22508

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

12455

109722

1.51

112.19

5.2

4.6

14.77

13.65

mm/h

11.17

11629

101736

(3028271) Lactate [Moles/volume] in Capillary blood

693

2757

2.57

112.06

2.0

1.9

1.74

1.72

mmol/l

0.22

678

2673

(3022806) Fractional oxyhemoglobin in Capillary blood

556

2023

2.80

107.24

1.9

89.82

89.05

2.18

549

1996

(40761536) Microorganisms panel - Urine sediment

1982

11870

1.75

107.13

4.9

4.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2208

13646

1.71

106.53

4.5

4.2

1.21

1.23

mmol/l

17.27

1930

11707

(3037467) Urinalysis macro (dipstick) panel - Urine

11883

104165

1.47

105.37

5.3

5.0

1.51

2.19

0.60

162

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

861

3970

2.22

99.74

4.0

2.3

214.32

208.52

1.03

819

3773

(3017461) Flecainide [Moles/volume] in Serum or Plasma

14.31

99.28

1.7

1.6

0.68

0.74

umol/l

0.25

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

14335

131239

1.61

99.11

5.1

4.7

1.30

mmol/l

0.39

13182

118275

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

14724

135791

1.67

97.71

7.9

7.4

40.68

40.40

mmol/mol

3.57

13813

125376

(3036489) Thrombin time

1079

5493

2.02

96.45

3.3

1.9

22.73

21.40

3.19

997

4966

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3922

28397

1.49

94.97

3.7

3.4

2.29

1.91

e6/l

1.51

1997

14388

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1019

5126

2.05

94.09

1.8

1.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

897

4317

2.13

93.17

3.8

2.1

86.38

89.39

3.67

874

4159

(3020564) Creatinine [Moles/volume] in Serum or Plasma

15791

149027

1.97

91.11

39.6

25.9

90.27

84.44

umol/l

59.53

15696

147194

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15638

147137

1.89

90.74

16.8

13.4

26.35

26.36

u/l

0.03

15306

142210

(43055442) Apixaban [Mass/volume] in Serum or Plasma

173

315

5.52

89.64

1.7

1.6

103.19

119.96

ug/l

1.13

145

262

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

14832

137642

1.64

88.65

6.2

5.8

6.15

6.12

mmol/l

1.84

13566

124654

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

15091

140695

1.69

88.26

7.0

6.4

2.37

2.54

mmol/l

106.59

14068

128991

(3023520) Reticulocytes [#/volume] in Blood

2693

18270

1.56

87.56

2.7

2.6

72.72

68.05

e9/l

8.08

1926

13640

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

14845

137882

1.64

87.32

6.1

5.6

4.16

4.42

mmol/l

192.50

13865

126823

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4356

32672

1.44

86.48

2.6

1.7

1.34

1.49

mg/l

1.74

3284

26040

(3021601) Nitrite [Presence] in Urine by Test strip

9415

80476

1.38

86.23

4.5

4.2

0.00

estimate

3.04

2543

16953

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8653

72963

1.38

86.20

3.3

3.0

—

estimate

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2714

18557

1.55

84.93

2.7

2.8

10.13

9.86

umol/l

0.25

2397

16466

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

14741

136848

1.61

84.86

6.0

5.5

1.33

1.41

mmol/l

110.13

13676

124863

(3006184) Hemoglobin [Mass/volume] in Capillary blood

906

4537

2.05

84.51

2.4

2.3

130.75

128.42

g/l

1.69

661

3483

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1580

9460

1.73

84.32

1.8

1.6

1.41

1.58

g/l

11.45

1329

8125

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4152

31079

1.44

82.64

3.5

3.3

1.05

1.20

e6/l

0.80

2260

17121

(3035350) Ketones [Presence] in Urine by Test strip

9488

81492

1.37

82.57

4.5

4.2

5.62

3.87

estimate

0.48

2607

17432

(3009261) Glucose [Presence] in Urine by Test strip

9505

81984

1.36

78.60

4.6

4.2

0.85

0.24

estimate

0.51

2392

16196

(1616796) Gas panel - Central venous blood

831

4156

2.05

77.68

4.3

3.9

—

(3007461) Platelets [#/volume] in Blood

15797

149927

1.87

77.22

42.8

29.2

224.58

240.29

e9/l

183.47

15609

146355

(3024731) MCV [Entitic mean volume] in Red Blood Cells

15797

149957

1.87

76.72

42.7

29.1

92.26

91.72

42.12

15695

148063

(3026361) Erythrocytes [#/volume] in Blood

15797

149962

1.87

76.64

42.8

29.2

4.44

4.45

e12/l

0.97

15562

145727

(3035941) MCH [Entitic mass]

15796

149950

1.87

76.63

42.7

29.1

30.56

30.51

3.20

15689

148055

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

15796

149960

1.87

76.47

44.5

29.8

40.40

40.27

0.94

15695

148009

(3010813) Leukocytes [#/volume] in Blood

15797

149974

1.87

76.44

42.8

29.2

6.99

6.92

e9/l

2.78

15565

145763

(3000963) Hemoglobin [Mass/volume] in Blood

15797

149976

1.87

76.41

43.2

29.4

134.25

134.55

g/l

1.50

15705

148129

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

10335

90903

1.35

71.70

3.8

3.5

68.18

56.91

u/l

16.68

9642

83936

(3025159) Blasts/Leukocytes in Blood

2132

14315

1.56

71.28

4.4

4.5

0.42

0.34

0.15

549

4143

(40760892) CBC W Ordered Manual Differential panel - Blood

4054

30912

1.41

70.73

5.3

5.0

—

(3026008) Bacteria identified in Urine by Culture

6158

50263

1.35

70.23

3.7

3.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

821

4238

1.98

70.12

1.6

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

2415

16725

1.51

69.88

2.5

2.7

65.28

66.12

g/l

6.09

2222

15257

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

8288

70849

1.33

68.27

2.5

2.4

—

(3021440) Promyelocytes/Leukocytes in Blood

2112

14279

1.54

68.22

4.2

4.3

0.12

0.11

0.05

562

4350

(3007853) Bacteria identified in Skin by Aerobe culture

2708

19308

1.47

67.68

2.0

1.9

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

666

3235

2.10

67.25

1.7

1.8

4.55

6.60

iu/l

0.44

218

1165

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1799

11796

1.58

66.41

1.8

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

710

3554

2.04

66.08

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

710

3554

2.04

66.08

1.4

—

(3017181) Myelocytes/Leukocytes in Blood

2184

15001

1.52

65.34

4.3

0.96

0.95

0.03

630

5036

(3002179) Metamyelocytes/Leukocytes in Blood

2094

14256

1.53

65.30

4.1

4.2

0.61

0.72

1.82

597

4825

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

556

2568

2.20

63.87

2.1

2.3

32.08

32.66

2.30

550

2551

(3021960) Folate [Moles/volume] in Serum or Plasma

6174

51165

1.32

60.78

1.9

1.8

19.21

19.88

nmol/l

3.09

5328

42992

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

501

2285

2.22

59.36

1.6

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2379

16983

1.46

58.23

2.2

2.3

0.19

0.20

g/l

6.18

2180

15755

(3003434) Protein [Mass/volume] in Pleural fluid

613

3046

2.04

58.17

1.6

1.5

28.60

42.57

g/l

0.80

532

2767

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2158

15148

1.48

57.50

2.5

2.6

37.07

50.80

u/l

1.54

1831

12878

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

6232

52143

1.30

55.74

2.8

60.47

66.60

u/l

1.50

5785

48212

(3020891) Body temperature

1392

8937

1.60

55.70

4.8

4.6

36.90

°c

0.05

1370

8854

(3041096) Erythrocytes [Presence] in Urine by Automated

5028

40850

1.32

55.65

4.3

3.8

0.41

0.33

estimate

0.15

2019

13233

(3012516) Albumin [Mass/volume] in Urine

6966

59167

1.30

55.57

3.5

3.6

49.75

51.63

mg/l

0.24

4812

38933

(3020682) Albumin/Creatinine [Ratio] in Urine

7091

60491

1.29

54.25

4.2

4.3

9.54

9.14

mg/mmol

0.22

4662

38550

(3009508) Creatinine [Moles/volume] in Urine

7068

60280

1.29

54.14

3.4

3.6

7.31

7.56

mmol/l

5.79

5838

50153

(3000012) Reticulocyte production index

585

2959

2.01

52.82

2.2

2.3

0.97

0.92

1.20

395

2097

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1479

9769

1.56

52.23

5.1

4.2

46.95

46.71

0.14

1461

9637

(3015736) pH of Urine

7542

65060

1.28

52.07

3.8

3.7

6.20

6.24

2.48

4032

35050

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4907

40178

1.31

50.11

3.0

2.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

6587

56147

1.28

48.97

3.5

3.7

2.34

2.35

mmol/l

5.45

6020

50519

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6948

59677

1.27

48.35

4.6

4.3

0.76

0.52

estimate

0.25

2160

13853

(3029937) Albumin [Presence] in Urine by Test strip

5550

46430

1.29

47.46

4.8

4.4

0.03

0.00

estimate

0.50

2330

15141

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1112

7021

1.62

47.43

3.1

2.2

503.77

658.12

ug/l

1.02

1077

6715

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

181

5.26

46.98

1.4

1.2

94.44

109.49

ug/l

0.41

109

(3037522) Nuclear Ab [Titer] in Serum

2508

18721

1.39

46.95

1.4

1.3

375.17

504.34

titre

5.84

522

4133

(3004451) EKG impression Narrative

284

1123

2.55

46.49

1.4

1.3

—

(3021901) Oxygen saturation in Capillary blood

728

4122

1.80

46.45

3.5

3.1

89.21

89.29

0.11

710

4010

(3028626) Oxygen [Partial pressure] in Capillary blood

807

4721

1.74

46.00

3.7

3.2

7.94

kpa

0.00

787

4611

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

209

716

2.93

45.16

2.1

85.62

95.66

3.44

203

685

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

465

2308

2.04

44.25

1.7

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

690

3915

1.79

43.70

1.7

1.6

—

(3045788) Cell count panel - Pleural fluid

440

2151

2.07

43.65

1.6

1.5

—

(40768806) Pleura Pathology biopsy report

454

2270

2.02

42.35

1.6

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1817

13069

1.43

41.67

1.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

210

754

2.80

41.66

13.6

3.2

1654.04

1308.24

mg/l

0.10

178

516

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

771

4585

1.71

41.38

1.7

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3203

25268

1.33

41.36

1.7

1.5

2.86

2.70

g/l

3.64

1909

14816

(46235355) HIV 1 and 2 tests - Meaningful Use set

2189

16294

1.39

41.20

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

946

5950

1.62

40.87

2.3

2.4

0.01

0.04

g/l

2.30

848

5326

(3028026) IgM [Mass/volume] in Serum or Plasma

1330

9084

1.50

39.77

2.1

2.0

1.24

1.37

g/l

1.15

1234

8248

(3024891) Influenza virus A+B Ag [Presence] in Specimen

574

3172

1.83

39.66

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

504

2684

1.90

39.13

1.6

1.5

1590.79

3276.04

e6/l

2.09

348

1900

(3049717) Cytology report of Urine Cyto stain

1220

8216

1.52

39.01

2.6

2.9

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

906

5748

1.60

37.72

2.3

2.4

0.00

g/l

0.15

798

5012

(3036782) Glucose [Moles/volume] in Pleural fluid

407

2050

2.00

37.22

1.5

1.4

6.51

6.31

mmol/l

0.89

386

1904

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1968

14622

1.39

37.17

1.6

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

767

4688

1.66

37.09

1.7

1.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

587

3336

1.78

36.96

1.3

30.55

36.82

u/l

0.93

527

2864

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

807

5003

1.64

36.91

3.2

2.9

1.87

1.70

mg/l

5.60

728

4496

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

851

5363

1.61

36.41

2.4

2.5

0.00

g/l

-0.00

795

5002

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1112

7456

1.52

36.23

1.4

1.6

8.93

16.66

iu/ml

1.79

178

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1786

13157

1.40

35.39

3.4

2.9

55.73

61.62

ml/min/173m2

9.78

823

5698

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

674

4039

1.69

35.13

2.2

1.9

12.52

12.25

mg/l

0.22

618

3766

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

564

3218

1.77

35.04

1.6

1.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

449

2392

1.90

34.84

1.6

1.5

67189.46

59469.26

e6/l

0.22

253

1374

(3005719) IgG [Mass/volume] in Serum or Plasma

1600

11599

1.41

34.78

2.8

2.9

10.80

10.69

g/l

0.44

1470

10682

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

313

1472

2.14

34.45

1.6

1.5

—

(3042733) HLA Ab [Presence] in Serum

138

436

3.17

34.42

5.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1207

8322

1.48

34.29

2.0

1.9

2.00

2.11

ug/l

0.14

1077

7346

(3026250) Tacrolimus [Mass/volume] in Blood

173

625

2.78

34.01

44.9

37.9

7.59

7.16

ug/l

1.92

156

546

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

8446

75900

1.22

34.00

2.4

2.3

92.22

94.23

pmol/l

3.83

4844

41298

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1065

7176

1.51

33.85

2.5

0.67

0.98

g/l

2.74

918

6100

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

403

2101

1.93

33.39

1.4

1.3

321.67

514.30

u/l

1.67

385

1995

(3042631) Mycobacterium sp identified in Specimen

476

2619

1.84

33.38

2.8

2.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

777

4893

1.61

33.33

1.5

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6857

60458

1.22

33.00

2.0

1.32

1.34

mmol/l

0.93

5443

49502

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

963

6420

1.53

32.16

2.1

1.8

37.55

38.82

u/l

1.02

794

5562

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

651

3958

1.67

32.12

1.6

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

574

3379

1.72

31.95

1.5

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4074

34081

1.25

31.87

3.0

3.3

2.46

mmol/l

0.95

3584

30547

(4094501) Cardiovascular stress test using bicycle ergometer

695

4305

1.64

31.87

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

610

3656

1.69

31.78

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1068

7297

1.49

31.69

3.1

3.4

48.49

47.39

mg/l

0.06

860

6245

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

222

939

2.38

31.56

1.4

15.05

14.22

umol/l

0.87

211

875

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1646

12182

1.38

31.53

7.4

7.0

24.41

24.51

mmol/l

0.48

1584

11682

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1028

6981

1.50

31.43

2.6

2.8

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1067

7303

1.49

31.38

3.1

3.4

63.10

64.24

mg/l

0.04

858

6249

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

487

2751

1.79

31.33

7.0

6.1

11.69

12.13

mg/l

1.47

453

2533

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

936

6238

1.53

31.29

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1247

8810

1.44

31.13

1.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

329

1643

2.02

30.88

1.3

13.89

14.35

u/l

0.04

304

1515

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

961

6517

1.50

29.55

3.1

3.3

2.28

4.55

ratio

2.51

494

3839

(3023183) Ammonium ion [Moles/volume] in Plasma

660

4124

1.62

29.22

2.6

2.5

31.53

33.34

umol/l

1.41

587

3681

(3038071) Oxygen [Partial pressure] in Mixed venous blood

127

422

3.02

29.14

5.5

7.8

5.64

5.44

kpa

0.31

127

422

(3027273) Bicarbonate [Moles/volume] in Venous blood

1248

8926

1.43

29.08

4.4

3.6

25.38

25.13

mmol/l

1.90

1213

8658

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3418

28292

1.26

28.86

1.3

1.81

1.84

u/ml

0.04

944

7007

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1735

13140

1.35

28.60

1.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

140

500

2.81

28.21

2.0

1.9

196.28

177.82

1.39

131

468

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1236

8879

1.42

28.07

5.5

5.0

1.57

1.60

0.73

1172

8449

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1808

13816

1.34

28.06

2.2

2.5

371.64

384.20

nmol/l

1.50

1707

12761

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

6.99

27.80

4.0

12.7

105.76

107.08

g/l

0.19

(3022145) Colonoscopy Study observation

2315

18346

1.30

27.68

1.4

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

115

375

3.07

27.29

2.1

2.0

228.36

205.66

1.35

110

359

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1463

10866

1.37

27.25

3.9

3.7

2.15

1.81

mmol/l

3.08

1073

8007

(1761868) Lipid panel - Serum or Plasma

5289

46115

1.21

26.81

4.0

3.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

136

493

2.76

26.68

5.8

7.9

6.07

5.96

kpa

0.66

127

423

(3015235) Bicarbonate [Moles/volume] in Capillary blood

992

6907

1.46

26.67

3.4

3.0

24.73

24.68

mmol/l

0.14

970

6785

(3018405) Lactate [Moles/volume] in Arterial blood

913

6270

1.48

26.34

4.4

4.1

1.40

1.41

mmol/l

0.08

892

6146

(3009343) pH of Capillary blood

1636

12441

1.34

26.14

4.1

3.8

7.42

0.32

1403

10366

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

560

3456

1.64

26.08

8.5

5.1

554.21

1342.02

iu/ml

0.83

106

519

(3034770) Mitochondria Ab [Titer] in Serum

613

3875

1.60

25.88

1.2

561.43

941.62

titre

—

105

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1101

7865

1.42

25.76

2.3

2.4

3.10

2.90

g/l

8.66

1015

7072

(40768797) Stomach Pathology biopsy report

2708

22070

1.27

25.73

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

233

1102

2.12

25.40

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1671

12811

1.33

25.22

4.1

3.8

5.13

kpa

0.03

1594

12174

(3010375) cycloSPORINE [Mass/volume] in Blood

162

659

2.46

25.20

31.5

30.7

121.73

110.54

ug/l

1.23

107

560

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

477

2853

1.69

25.09

1.5

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

726

4803

1.53

25.09

3.2

3.5

—

428.62

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1159

8404

1.40

24.88

2.3

2.4

7.21

7.44

g/l

4.90

1075

7607

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1158

8396

1.40

24.87

2.3

2.4

4.14

4.18

g/l

0.85

1075

7608

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

226

1066

2.13

24.82

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1155

8380

1.40

24.71

2.3

2.4

3.84

3.74

g/l

1.22

1066

7594

(3035880) pH of Pleural fluid

237

1141

2.09

24.68

1.4

1.3

7.43

7.39

2.42

166

807

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1725

13330

1.32

24.61

4.4

4.1

113.00

96.61

ng/l

8.76

1472

11379

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2878

23764

1.25

24.27

1.3

42.13

39.34

iu/ml

0.25

833

7197

(40768804) Tissue Pathology biopsy report

6589

58995

1.19

24.19

2.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

151

4.17

23.77

2.5

2.3

0.63

0.69

ug/l

0.67

151

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

339

1869

1.82

23.73

1.4

1.2

5.64

3.67

u/ml

0.71

148

688

(3051611) Lipemic interference index of Serum or Plasma

316

1711

1.86

23.44

4.5

3.6

12.17

12.86

index

0.61

218

906

(3035947) Staphylolysin Ab [Units/volume] in Serum

181

805

2.26

23.05

1.2

1.1

3.25

4.07

iu/ml

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

802

5522

1.47

22.82

1.7

0.35

0.33

mg/l

0.36

414

2684

(3011397) Hemoglobin [Presence] in Urine by Test strip

4415

38290

1.20

22.82

4.0

0.17

0.27

0.25

441

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

537

3391

1.60

22.80

1.5

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

415

2455

1.70

22.78

1.5

1.4

150.50

153.15

au/ml

0.17

129

731

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

242

1213

2.00

22.61

1.5

1.4

—

(3000494) Fungus identified in Specimen by Culture

2343

19033

1.26

22.61

1.6

1.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

735

4985

1.49

22.56

1.4

1.5

16.15

15.24

iu/ml

0.05

102

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

6.54

22.42

1.4

155.95

128.90

ug/l

0.27

(3007566) Smooth muscle Ab [Titer] in Serum

602

3938

1.54

21.93

1.2

106.00

134.37

titre

0.63

355

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

342

1939

1.77

21.84

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

287

1543

1.87

21.81

1.4

15.07

12.93

u/l

2.64

279

1485

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

949

6807

1.41

21.65

1.2

106.70

123.15

u/ml

0.70

297

2290

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

998

7239

1.40

21.34

2.3

2.4

10.41

10.21

g/l

0.77

907

6352

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

687

4656

1.49

21.17

1.5

1.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

309

1722

1.80

20.93

1.2

54.78

65.93

u/l

2.07

265

1493

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

325

1844

1.77

20.73

1.4

1.2

4.61

3.80

u/ml

0.64

170

865

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

220

3.36

20.55

1.3

1.2

81.25

79.45

0.16

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

450

2800

1.62

20.35

1.5

1.4

—

(3017569) Oxygen content in Arterial blood

221

1117

1.99

20.23

2.4

2.3

15.93

15.79

0.24

221

1117

(3014051) Protein [Presence] in Urine by Test strip

4678

41133

1.19

20.21

3.4

3.2

0.10

0.07

0.25

1257

(3002256) Pathology report gross observation

2566

21357

1.23

19.69

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

329

1903

1.74

19.65

3.5

3.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

642

4373

1.48

19.32

1.7

1.5

1.18

1.19

g/l

0.07

617

4163

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1631

20271

0.78

19.18

5.6

5.4

32.87

32.70

0.27

1231

13030

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1739

13886

1.28

19.14

1.5

—

6.15

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

626

4253

1.49

19.08

1.7

1.5

0.24

g/l

0.19

600

4030

(3007930) Methemoglobin/Hemoglobin.total in Blood

1088

8148

1.35

19.07

5.9

5.2

0.83

0.87

3.54

1029

7732

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

441

2777

1.60

19.01

1.5

1.4

19.16

18.88

u/ml

—

(3040151) Glucose [Moles/volume] in Capillary blood

360

2156

1.68

18.94

5.7

9.7

7.39

7.48

mmol/l

0.18

305

1769

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

147

657

2.24

18.60

1.1

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

192

955

2.02

18.43

1.2

1.3

26.65

28.66

u/l

0.30

165

779

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

5.46

18.24

2.5

2.1

1.80

2.07

mg/l

0.48

(44806118) Parainfluenza type 4 nucleic acid detection

362

2199

1.66

18.06

1.8

1.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

3705

32181

1.19

18.06

1.9

1.8

1217.32

1144.78

nmol/l

4.50

2863

24098

(44790047) Parainfluenza type 1 nucleic acid detection

362

2200

1.65

18.03

1.8

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

362

2200

1.65

18.03

1.8

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

362

2200

1.65

18.03

1.8

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

427

2709

1.59

17.86

3.4

2.6

1013.76

4883.13

u/ml

0.69

183

(3005532) Lymphocytes/Leukocytes in Pleural fluid

155

724

2.14

17.61

1.5

1.4

67.00

62.60

0.86

126

591

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

440

2823

1.57

17.54

1.4

11.30

14.18

u/ml

—

(3035320) C reactive protein [Mass/volume] in Body fluid

221

1174

1.89

17.53

3.3

2.8

28.90

32.58

mg/l

0.70

174

866

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

193

980

1.97

17.51

1.2

1.3

107.99

98.80

u/l

0.39

169

816

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

189

953

1.99

17.49

4.0

3.9

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

278

1590

1.76

17.33

1.6

1.5

23.18

28.29

2.10

188

988

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

378

2349

1.62

17.25

1.3

1.2

302.96

276.85

u/ml

0.92

254

1430

(3023419) Bacteria identified in Sputum by Culture

393

2466

1.60

17.23

2.6

2.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2623

22158

1.21

17.18

1.3

16.01

14.14

u/ml

0.27

974

7851

(3000475) Leukocytes [#/volume] in Synovial fluid

648

4528

1.44

17.11

1.7

1.6

19963.97

14852.29

e6/l

1.02

446

3208

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

164

792

2.07

17.10

1.8

2.0

334.52

1587.09

u/l

1.23

237

(3009871) Measles virus Ab [Titer] in Serum

102

404

2.53

16.96

1.4

1.6

3320.00

3592.73

titre

0.09

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

222

3.11

16.93

1.2

72.73

72.44

0.02

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

431

2778

1.56

16.85

1.2

—

(3003694) ABO and Rh group [Type] in Blood

4495

39886

1.17

16.69

1.4

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

311

2.73

16.57

1.3

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1774

14439

1.25

16.50

1.8

1.58

0.14

1488

12268

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

187

963

1.95

16.32

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

187

964

1.94

16.27

1.4

1.5

—

(3045716) Anion gap in Serum or Plasma by calculation

333

2043

1.64

16.03

3.4

2.9

10.51

10.77

mmol/l

0.58

326

2020

(3024471) HLA-A [Type]

104

428

2.43

15.97

1.0

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

199

3.16

15.96

1.2

1.3

7.48

160249.80

nmol/l

0.72

166

(3001893) Eosinophils/Leukocytes in Pleural fluid

134

616

2.18

15.90

1.5

1.4

1.88

3.04

1.02

113

515

(3024932) HLA-DR beta [Type]

102

417

2.45

15.89

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7297

67265

1.14

15.74

2.6

2.4

78.04

78.82

nmol/l

1.49

6530

59526

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5022

45112

1.16

15.64

3.5

3.4

0.78

0.79

ug/l

0.57

3535

31503

(3025941) Bacteria identified in Stool by Culture

941

7106

1.34

15.60

1.3

—

(3019225) pH of Specimen

1379

17085

0.79

15.58

4.6

4.5

7.37

7.36

0.72

1054

12266

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

353

2214

1.60

15.55

1.3

0.24

0.27

nmol/l

0.17

192

(4268621) Lupus anticoagulant assay

229

1281

1.79

15.46

2.6

2.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

164

3.35

15.30

1.3

1.1

0.06

0.32

u/ml

0.70

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

234

1329

1.77

15.02

1.3

1.1

89.88

96.38

2.68

225

1229

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

345

2177

1.59

14.84

1.3

0.71

2.84

nmol/l

1.27

329

2087

(4195642) Thrombophilia screening test

279

1671

1.68

14.79

1.3

1.2

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

11700

111563

1.15

14.78

37.8

25.3

330.90

332.16

g/l

39.95

11634

110914

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4015

35591

1.16

14.76

1.9

1.8

31779317.16

29660832.81

pmol/l

0.08

3238

28887

(3043409) Potassium [Moles/volume] in Arterial blood

716

5230

1.38

14.71

4.9

4.5

3.98

3.91

mmol/l

3.11

709

5188

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

280

1682

1.67

14.68

1.3

1.1

96.35

115.55

14.45

258

1509

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

302

1850

1.64

14.67

1.3

1.4

—

nmol/l

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

211

1171

1.81

14.65

1.1

1.2

158.75

147.43

titre

0.08

206

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

311

1922

1.62

14.59

1.3

0.21

nmol/l

0.08

265

1559

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

782

5824

1.36

14.22

1.3

—

(40763791) Oxygen content in Venous blood by calculation

6.38

14.02

8.4

4.2

11.41

12.07

ml/dl

0.26

(3048929) Epstein Barr virus Ab [Presence] in Serum

467

3188

1.47

13.99

1.3

1.2

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

119

553

2.15

13.81

1.4

18.04

21.82

0.90

108

492

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

309

2.56

13.58

1.5

11.43

10.99

0.06

152

(3005322) IgE [Units/volume] in Serum or Plasma

999

7762

1.30

13.53

1.3

278.86

286.04

u/ml

0.06

943

7173

(3008037) Lactate [Moles/volume] in Venous blood

658

4816

1.38

13.37

4.7

3.3

1.62

1.64

mmol/l

0.19

633

4704

(3014148) Varicella zoster virus Ab [Titer] in Serum

222

1286

1.73

13.35

1.2

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

8187

76552

1.13

13.18

5.9

6.0

2.78

3.47

ug/l

2.28

7368

69093

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

208

1193

1.75

12.97

2.4

2.3

14.73

29.04

iu/ml

4.08

176

(3044242) Glucose [Moles/volume] in Arterial blood

196

1114

1.76

12.63

2.2

1.9

8.28

8.18

mmol/l

0.15

196

1114

(3020961) Endomysium IgA Ab [Titer] in Serum

699

5213

1.35

12.63

1.1

140.73

194.52

titre

0.40

134

(3006571) Granulocytes/Leukocytes in Synovial fluid

328

2133

1.54

12.45

1.6

1.5

66.76

60.91

2.20

229

1339

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.99

12.27

1.1

1.3

—

(3011985) Renin [Units/volume] in Plasma

340

2238

1.53

12.22

1.3

1.4

68.42

63.86

mu/l

0.16

301

1990

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

278

1749

1.59

12.20

1.2

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

3.73

12.16

1.3

1.2

3716.87

2767.79

ng/l

0.49

(3024980) IgG subclass 4 [Mass/volume] in Serum

362

2419

1.50

12.12

1.4

1.7

0.85

0.88

g/l

0.18

259

1872

(3037756) Immunofixation for Serum or Plasma

605

4462

1.36

11.77

1.5

1.6

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

241

1478

1.63

11.76

1.2

—

38.78

—

(3017732) Neutrophils [#/volume] in Blood

2237

19239

1.18

11.68

3.1

3.3

4.79

e9/l

0.00

1995

16074

(40762365) Oxygen content in Arterial blood by calculation

297

2.46

11.62

2.8

3.1

14.88

14.66

ml/dl

0.26

278

(3048689) Calprotectin [Mass/mass] in Stool

1881

15940

1.20

11.61

2.2

2.3

154.28

162.45

ug/g

0.42

1458

12606

(3014891) Appearance of Pleural fluid

277

2.49

11.31

1.6

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

315

2077

1.52

11.27

1.3

337.68

335.21

pmol/l

0.02

271

1709

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

170

964

1.77

11.11

1.6

1.5

6.41

7.21

u/l

0.28

122

763

(3034426) Prothrombin time (PT)

386

2.23

10.98

1.4

1.2

31.36

28.06

4.14

386

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

303

1997

1.52

10.88

1.2

—

19.45

u/ml

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

333

2.31

10.74

1.2

81.59

99.56

2.68

311

(3015171) Extractable nuclear Ab [Units/volume] in Serum

659

5000

1.33

10.65

1.2

0.37

0.92

u/ml

2.06

440

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

341

2.29

10.62

6.2

7.0

10.76

10.39

0.58

341

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

150

3.00

10.54

1.2

1.1

11.68

20.76

iu/ml

0.82

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

239

1507

1.59

10.46

2.0

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

464

3351

1.39

10.32

1.3

191.92

291.03

titre

0.67

252

(3042111) Morphology [Interpretation] in Bone marrow Narrative

463

3346

1.39

10.26

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

158

900

1.76

10.21

1.9

2.1

18.07

32.04

umol/l

1.03

(3023420) DNA double strand Ab [Units/volume] in Serum

731

5693

1.29

9.78

1.9

1.6

8.81

7.74

iu/ml

0.25

164

1336

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

803

6385

1.27

9.12

1.1

41.69

5.34

u/ml

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

353

2488

1.42

9.09

1.2

1.1

—

(4062490) Immunoglobulin typing, IgG

225

1453

1.55

8.96

1.3

1.4

—

(3024263) Appearance of Synovial fluid

146

846

1.73

8.95

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

510

3831

1.34

8.89

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

212

2.50

8.85

1.1

19.31

19.94

u/l

0.09

142

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

330

2.18

8.83

1.1

71.54

83.82

1.91

175

(42529406) Shigella sp [Presence] in Stool by Culture

510

3841

1.33

8.74

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

325

2.18

8.74

1.1

1.2

64.89

83.73

2.77

177

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

298

2052

1.46

8.72

1.1

1.62

1.55

g/l

2.15

287

1845

(3002331) Protein [Mass/volume] in Peritoneal fluid

452

1.99

8.68

1.4

32.51

41.55

g/l

0.30

346

(3027135) IgG subclass 1 [Mass/volume] in Serum

227

1481

1.54

8.65

1.3

1.4

7.32

6.96

g/l

0.50

138

1067

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1483

12627

1.19

8.63

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

504

3801

1.33

8.57

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

226

1481

1.53

8.45

1.3

1.4

0.45

g/l

0.05

135

1071

(3028192) IgG subclass 2 [Mass/volume] in Serum

226

1482

1.53

8.42

1.3

1.4

2.78

2.96

g/l

0.67

136

1069

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

158

954

1.66

8.35

1.2

81.24

82.69

0.11

(3016650) Hepatitis A virus Ab [Presence] in Serum

320

2256

1.42

8.27

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

138

807

1.71

8.23

1.5

2.47

3.83

0.85

166

(3026692) Albumin [Mass/volume] in Peritoneal fluid

518

1.89

8.17

1.8

1.3

17.49

13.11

g/l

5.53

381

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1364

0.49

7.97

1.0

254.04

329.97

ng/l

3.60

964

(3012565) Volume of 24 hour Urine

138

817

1.69

7.88

2.2

2.3

1864.23

1921.63

0.28

117

709

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1370

0.50

7.85

1.0

31.54

41.74

ng/l

3.04

952

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1367

0.50

7.80

1.0

699.20

719.82

ng/l

0.13

930

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

14.96

7.69

1.1

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

216

2.36

7.58

2.4

2.0

—

(3011544) Albumin [Mass/volume] in Pleural fluid

216

2.36

7.58

1.4

1.1

14.21

17.63

g/l

2.97

196

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

157

2.61

7.53

2.8

2.3

67.48

58.35

0.94

103

(36660697) Celiac disease serology panel - Serum

1198

10141

1.19

7.46

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

347

2.04

7.45

2.9

1.2

1.19

1.17

mmol/l

1.79

347

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

275

3851

0.71

7.43

1.3

569.20

593.93

mg/l

0.33

265

3675

(3003181) Sodium [Moles/volume] in Urine

468

3569

1.32

7.42

1.4

59.81

61.98

mmol/l

0.58

378

2879

(40768443) Skin Pathology biopsy report

901

7434

1.22

7.36

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

248

1710

1.45

7.29

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

110

2.90

7.20

1.1

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

407

1.94

7.17

1.7

1.4

17.43

16.13

pmol/l

0.47

327

(3019832) Treponema pallidum Ab [Presence] in Serum

611

4851

1.27

7.11

1.5

1.6

—

(3039000) Anion gap in Blood by calculation

512

3978

1.29

7.09

7.1

6.9

11.39

11.27

mmol/l

0.34

467

3599

(3018572) Chloride [Moles/volume] in Blood

512

3978

1.29

7.09

7.1

6.9

105.30

104.91

mmol/l

1.18

467

3600

(3023383) Lactate [Moles/volume] in Pleural fluid

115

669

1.72

7.06

1.4

1.3

2.89

3.55

mmol/l

1.91

104

620

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1733

15183

1.15

7.02

2.7

2.6

0.49

0.45

e6/l

0.30

1678

14677

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

113

658

1.72

6.92

1.2

1.3

100.60

296.66

ug/l

1.36

351

(44786800) Granulocytes/Leukocytes in Body fluid

245

2.20

6.88

1.4

1.3

20.69

25.62

0.53

193

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

131

796

1.65

6.84

2.4

2.7

217.55

205.30

u/l

0.93

131

785

(3041918) Cholesterol [Moles/volume] in Pleural fluid

415

1.90

6.79

1.3

1.2

1.32

1.52

mmol/l

1.23

263

(4035726) Immunohistochemistry procedure

1668

14618

1.15

6.73

1.5

1.4

—

(44806420) Estimation of glomerular filtration rate

175

1147

1.53

6.65

2.6

2.7

—

(3047181) Lactate [Moles/volume] in Blood

698

5677

1.24

6.59

6.2

6.0

1.36

1.35

mmol/l

0.12

610

5049

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

214

2.24

6.41

5.1

5.9

63.24

52.12

ug/min

0.39

182

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1714

15122

1.14

6.28

1.3

—

(3045414) Leukocytes [Presence] in Urine

1817

16099

1.14

6.25

2.2

0.01

estimate

0.29

396

2982

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

350

1.94

6.24

1.1

1.2

541.39

265.40

pmol/l

0.65

257

(3038515) Glucose [Moles/volume] in Venous blood

517

4092

1.27

6.22

5.3

3.5

7.34

7.72

mmol/l

3.03

498

3997

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

106

626

1.69

6.21

1.2

1.1

1.11

1.07

ratio

3.19

505

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6486

61403

1.09

6.19

4.8

22.30

22.17

0.31

3324

32321

(3037692) Legionella sp identified in Specimen by Organism specific culture

107

636

1.68

6.13

1.7

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

134

2.53

5.97

1.0

1.1

177.00

206.15

u/ml

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

427

1.82

5.95

1.1

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

248

3397

0.72

5.95

1.3

3.78

3.88

mmol/l

0.98

234

3216

(3047189) Immunofixation for 24 hour Urine

147

958

1.53

5.79

1.6

1.7

—

(4281824) Cell count and differential, peritoneal fluid

199

1380

1.44

5.78

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

784

9290

0.83

5.73

2.1

2.2

3.57

3.54

ratio

0.37

656

7614

(3000093) Morphology [Interpretation] in Blood Narrative

254

1843

1.38

5.70

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

340

2580

1.32

5.69

2.2

2.4

1.33

1.19

g/24h

0.31

212

1518

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

153

1011

1.51

5.67

2.2

1.9

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

126

2.53

5.64

3.0

2.2

9.87

17.08

0.97

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

246

2.07

5.64

2.5

2.7

68.96

67.37

mg/l

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

550

4439

1.24

5.63

1.5

0.30

6.09

iu/ml

2.00

108

922

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

263

1924

1.37

5.62

1.2

204.26

205.37

miu/ml

0.01

585

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

195

1355

1.44

5.61

1.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

106

647

1.64

5.53

6.6

6.5

24.58

25.07

mmol/l

0.60

576

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

359

1.86

5.50

2.7

2.4

6.84

7.83

mmol/l

1.54

236

(3020491) Glucose [Moles/volume] in Blood

161

1085

1.48

5.44

2.0

1.9

7.29

mmol/l

0.01

123

730

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

136

886

1.53

5.40

2.2

66.38

131.07

ug/min

0.98

211

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

405

1.80

5.38

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

100

607

1.65

5.35

1.5

1.6

3.84

9.75

nmol/l

0.84

523

(3002079) Sodium [Moles/time] in 24 hour Urine

106

653

1.62

5.35

1.2

189.14

168.95

mmol/24h

0.97

106

653

(3023487) Leukocytes [#/volume] in Peritoneal fluid

113

708

1.60

5.32

2.2

2.0

9991.89

3241.32

e6/l

0.40

488

(3044007) Cell count panel - Peritoneal fluid

588

1.65

5.23

1.8

2.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1064

9202

1.16

5.17

2.4

2.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

396

1.79

5.16

1.7

1.6

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

598

1.64

5.15

2.3

1.8

14234.34

14832.12

e6/l

0.03

319

(21494890) Protein electrophoresis panel - 24 hour Urine

291

2195

1.33

5.13

1.8

2.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

101

622

1.62

5.12

2.4

2.6

0.61

mmol/l

0.28

101

622

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

211

1516

1.39

5.08

1.2

1.3

—

(3000285) Sodium [Moles/volume] in Blood

384

1.79

5.06

1.3

1.2

138.47

138.43

mmol/l

0.02

316

(3008536) Aspergillus sp Ab [Presence] in Serum

356

1.82

5.02

1.6

2.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

596

4923

1.21

4.94

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

276

1.92

4.80

12.1

11.5

5.61

5.41

mmol/l

0.15

276

(3042010) Triglyceride [Moles/volume] in Pleural fluid

327

1.83

4.73

1.3

0.67

1.14

mmol/l

0.60

215

(3010144) Erythrocytes [#/volume] in Synovial fluid

234

1732

1.35

4.72

1.4

287426.65

139402.01

e6/l

1.32

161

1151

(3020911) Cortisol [Moles/time] in 24 hour Urine

415

1.73

4.71

1.3

1.4

152.42

324.21

nmol/24h

0.78

415

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

152

1045

1.45

4.71

2.1

1.9

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

508

1.65

4.62

1.4

1.3

65.03

58.36

1.04

431

(3016038) Potassium [Moles/volume] in Urine

176

1248

1.41

4.62

1.1

35.67

34.66

mmol/l

0.23

155

1062

(21491868) Cryoglobulin [Mass/volume] in Serum

532

1.63

4.58

1.2

0.12

0.69

g/l

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

135

913

1.48

4.56

1.1

—

0.55

—

(3036603) Volume of Urine

179

1277

1.40

4.54

1.6

1988.72

1882.72

0.82

174

1234

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

303

2341

1.30

4.54

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

256

3337

0.76

4.50

1.5

1.4

1396.95

2080.66

e6/l

0.35

197

2672

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

253

3299

0.76

4.46

1.5

1.4

86.58

28.91

e6/l

0.53

177

2481

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

229

1.96

4.38

1.4

75.67

70.15

0.66

190

(3000330) Specific gravity of Urine by Test strip

1011

8830

1.15

4.35

3.8

1.02

ratio

3.20

915

8049

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

544

6465

0.83

4.19

1.8

3.21

3.39

mmol/l

3.07

409

4694

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.73

4.15

1.8

1.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.73

4.15

1.9

1.6

—

(4146454) Self-monitoring of blood glucose

161

2208

0.72

4.04

2.8

2.7

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.85

4.03

3.6

6.5

0.96

0.98

mg/l

0.03

(3034274) Bile acid [Moles/volume] in Serum --fasting

591

1.55

4.01

1.4

1.5

8.51

14.20

umol/l

1.79

422

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

123

2.27

3.99

1.0

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

476

1.62

3.94

1.2

1.1

7.22

10.19

u/ml

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

348

1.72

3.91

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

513

4283

1.20

3.89

1.6

1.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

323

2571

1.26

3.87

1.8

4.67

4.80

mmol/24h

0.28

293

2225

(3006922) Hepatitis E virus Ab [Presence] in Serum

149

1064

1.40

3.83

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

158

1145

1.38

3.73

1.2

99.08

104.82

pmol/l

0.67

158

1145

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

236

1.86

3.73

1.3

1.2

59.39

493.55

ng/l

0.69

157

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

141

2.12

3.66

1.5

1.6

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

303

1.75

3.66

1.4

1.3

47.89

281.38

u/l

0.86

216

(3020650) Glucose [Presence] in Urine

455

1.60

3.65

1.5

1.7

0.00

0.05

estimate

2.48

455

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1796

16410

1.10

3.64

2.4

2.3

13.03

13.09

nmol/l

0.11

1579

14596

(21494755) Public health laboratory ask at order entry panel

587

6837

0.85

3.63

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

295

2348

1.26

3.57

1.8

282.27

290.26

mu/l

0.20

274

2185

(3016750) Collection duration of Urine

147

1064

1.38

3.52

2.3

2.2

490.27

497.70

min

0.38

773

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

905

0.60

3.50

1.2

1.1

44.75

45.74

mg/l

0.08

769

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

447

3727

1.20

3.48

1.2

1.3

—

(37021550) Renin [Units/volume] in Plasma --upright

317

1.70

3.42

1.2

132.62

67.61

mu/l

0.85

232

(3022313) Gas panel - Capillary blood

988

8767

1.13

3.41

4.3

4.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

131

937

1.40

3.39

1.1

87.79

88.87

u/l

0.06

105

827

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

479

4036

1.19

3.33

2.0

1.9

198.73

201.72

pmol/l

0.30

443

3786

(3045142) Bone marrow Pathology biopsy report

278

2231

1.25

3.18

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

854

0.62

3.13

1.1

282.40

320.11

mg/l

1.00

758

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

128

927

1.38

3.11

1.1

27.27

28.57

u/l

0.09

103

811

(3025577) Chromium [Mass/volume] in Blood

163

1226

1.33

3.10

2.2

2.00

2.18

ug/l

0.35

141

1012

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

186

2394

0.77

3.10

1.1

1.2

0.67

0.63

ratio

0.51

427

(3009214) Lutropin [Units/volume] in Serum or Plasma

356

2941

1.21

3.10

1.4

9.36

9.23

u/l

0.06

275

2338

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

100

695

1.44

3.07

1.5

1.7

111.36

100.16

umol/l

0.14

354

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

140

1031

1.36

3.07

2.0

1.9

15.39

16.98

1.01

135

999

(3002619) Bacteria identified in Specimen by Culture

421

1.57

3.06

1.4

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

136

998

1.36

3.05

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

134

983

1.36

3.02

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

337

1.63

3.01

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

423

0.47

2.99

1.1

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

106

2.16

2.99

1.1

—

(3017704) Immunofixation for Urine

150

1124

1.33

2.95

1.4

1.6

—

(3019174) dRVVT (LA screen)

2.23

2.93

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

131

963

1.36

2.92

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

138

1023

1.35

2.92

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

141

1.98

2.91

1.2

1.1

—

(3008295) Osmolality of Serum or Plasma

242

1935

1.25

2.90

1.3

275.89

276.63

mosm/kgh2o

0.16

175

1479

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

159

1206

1.32

2.88

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

599

1.45

2.84

2.8

2.0

52.39

58.82

ug/l

0.38

585

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

137

1022

1.34

2.80

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

604

5266

1.15

2.79

1.5

1.4

262.51

259.58

ug/g

0.13

377

3237

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

123

904

1.36

2.77

1.3

1.4

1.11

1.68

u/ml

0.50

566

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

346

1.59

2.74

1.8

1.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

579

5046

1.15

2.70

1.8

44.02

43.90

nmol/l

0.05

565

4875

(1175426) CD3 cells/Lymphocytes in Blood

144

1089

1.32

2.69

2.1

1.9

71.58

70.44

0.33

137

1032

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

125

926

1.35

2.69

1.9

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.23

2.67

1.5

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

310

1.61

2.65

1.7

2.0

7.74

8.62

mg/l

0.56

255

(4027681) Cerebrospinal fluid IgG ratio and IgG index

621

0.59

2.64

1.3

1.2

0.59

0.63

ratio

0.12

363

(3026470) Cobalt [Mass/volume] in Blood

164

1267

1.29

2.64

2.2

4.22

3.55

ug/l

0.40

157

1166

(40759836) Histone Ab [Presence] in Serum by Immunoblot

139

1054

1.32

2.57

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

762

6797

1.12

2.50

4.4

4.1

24.91

24.81

mmol/l

0.41

696

6185

(3013727) Leukocytes other/Leukocytes in Blood

535

1.44

2.45

2.5

4.0

55.21

53.65

0.29

518

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

141

1080

1.30

2.44

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

801

0.66

2.43

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

771

6902

1.12

2.40

3.0

3.5

946.89

1821.46

u/ml

0.70

646

6011

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

226

1.68

2.39

1.0

1.1

1140.00

862.50

titre

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

280

1.60

2.38

1.1

—

(4024509) Urine culture

847

7626

1.11

2.38

2.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

385

1.50

2.33

1.1

1.3

13.71

12.84

mm/h

0.14

385

(3026051) Granulocytes/Leukocytes in Pleural fluid

492

1.44

2.31

1.4

18.16

23.04

0.92

414

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

538

4724

1.14

2.30

1.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.21

2.29

4.6

4.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

299

1.57

2.29

1.0

1.1

0.61

0.67

umol/24h

0.59

133

(37208534) Antinuclear antibody arbitrary concentration in serum

421

1.47

2.24

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

120

1.91

2.23

2.3

3.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

200

1622

1.23

2.20

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

213

0.42

2.17

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

138

1077

1.28

2.12

1.1

2353.01

285.00

mg/l

0.50

130

970

(3016330) Potassium [Moles/time] in 24 hour Urine

196

1.68

2.12

1.3

1.2

—

82.23

—

(3000060) B lymphocytes [#/volume] in Blood

274

1.57

2.10

1.7

1.9

1.47

2.18

e9/l

0.16

127

(3009466) Valproate [Moles/volume] in Serum or Plasma

175

2150

0.81

2.09

4.1

4.8

337.32

342.52

umol/l

0.21

152

1835

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

215

1771

1.21

2.06

2.7

2.9

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

1231

0.75

2.04

1.1

1.3

2.34

2.24

mmol/l

0.16

1143

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

522

1.40

2.04

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

317

2707

1.17

2.03

1.2

50.58

48.16

u/ml

0.07

255

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.99

2.03

1.2

1.3

1.50

2.00

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

399

1.45

2.00

1.6

1.3

—

(21494434) Karyotype in Bone marrow

215

1777

1.21

2.00

1.1

1.2

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

125

1.84

2.00

1.3

1.4

0.96

0.90

ml/s/173m2

0.07

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1896

20036

0.94

2.00

11.3

7.9

—

(3013466) aPTT in Blood by Coagulation assay

2.27

1.96

1.1

39.24

38.08

0.15

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

222

2644

0.83

1.95

1.2

1.41

1.48

g/l

4.88

222

2644

(3004775) Volume in Urine collected for unspecified duration

184

1502

1.22

1.95

2.3

699.00

687.29

0.11

113

996

(40757373) Influenza virus identified in Isolate

337

1.48

1.92

1.9

1.6

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

329

1.49

1.92

1.7

1.2

379.50

231.03

titre

—

(40768795) Lymph node Pathology biopsy report

197

1622

1.21

1.92

1.2

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

641

0.67

1.92

1.0

1.1

0.92

1.18

u/l

3.57

288

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

106

812

1.30

1.91

2.1

1.9

39.16

39.88

g/l

0.60

106

812

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

389

1.44

1.86

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

405

3550

1.14

1.85

3.3

1.7

5.90

5.00

mg/l

0.59

344

2685

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.20

1.82

1.0

1.2

1.29

1.41

u/field

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

517

1.37

1.81

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.26

1.79

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

302

1.49

1.79

1.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.91

1.78

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

640

5784

1.11

1.76

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

157

1279

1.23

1.73

1.3

406.36

494.58

titre

0.18

120

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

573

1.34

1.73

1.2

1.1

1616.14

1605.37

miu/ml

0.03

573

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1231

0.78

1.72

1.0

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

153

1245

1.23

1.71

1.3

176.00

66.00

titre

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

550

4941

1.11

1.70

1.6

31.96

25.53

u/ml

0.52

945

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

106

828

1.28

1.69

1.9

2.70

2.83

u/field

0.05

565

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

241

2050

1.17

1.68

1.5

—

(3001729) Color of Synovial fluid

133

1.72

1.67

1.7

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

495

4426

1.12

1.67

2.4

109.23

120.81

ug/min

0.28

292

2605

(3037121) Protein [Mass/volume] in Urine

668

6070

1.10

1.66

2.8

3.3

597.50

493.03

mg/l

0.17

317

2891

(3013139) Helicobacter pylori Ag [Presence] in Stool

1019

9435

1.08

1.66

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

349

1.43

1.65

1.3

1.2

—

(3019150) Specific gravity of Urine by Refractometry

3718

35790

1.05

1.65

4.7

4.5

1.02

1.10

kg/l

0.82

2616

24362

(3035611) Eosinophils/Leukocytes in Synovial fluid

112

1.78

1.62

1.8

1.5

1.32

0.84

0.28

(3017354) Segmented neutrophils/Leukocytes in Blood

182

2161

0.84

1.61

3.1

3.6

57.91

58.83

0.20

160

1835

(3021374) Sirolimus [Mass/volume] in Blood

3.56

1.61

5.6

9.6

9.10

6.89

ug/l

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

633

1.31

1.60

2.7

2.6

10.12

10.10

kpa

0.02

633

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

633

1.31

1.60

2.7

2.6

4.93

4.90

kpa

0.08

633

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

206

1738

1.18

1.60

1.6

1.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

544

0.68

1.59

2.3

3.0

27.03

29.01

umol/l

0.54

412

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

436

0.64

1.59

2.9

2.8

2.86

1.77

ratio

0.80

395

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

180

1502

1.20

1.59

1.5

1.7

27.93

26.53

u/ml

0.10

309

(3008116) Ketones [Moles/volume] in Urine by Test strip

386

1.40

1.58

1.4

0.22

0.30

mmol/l

0.75

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.32

1.58

6.9

8.7

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

281

1.46

1.51

1.3

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

108

1.75

1.48

1.3

0.05

0.07

g/l

0.83

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

342

3018

1.13

1.48

1.1

4.12

3.23

0.74

265

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2071

19712

1.05

1.47

3.7

4.4

10.55

27.54

ug/l

7.12

1678

16588

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

149

1234

1.21

1.45

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

108

867

1.24

1.42

1.1

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

101

807

1.25

1.39

1.1

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

135

1621

0.83

1.39

1.4

—

(3011412) CD3 cells [#/volume] in Blood

166

1395

1.19

1.39

2.3

2.2

926.46

1089.98

e6/l

1.89

156

1255

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

655

0.73

1.39

1.0

1.1

132.30

517.01

ng/l

—

196

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.93

1.35

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

521

4743

1.10

1.31

1.5

1.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

224

1.47

1.31

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

101

1238

0.81

1.30

2.3

2.9

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

192

0.52

1.28

1.1

12.17

8.83

mg/g

—

180

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

437

1.32

1.28

1.0

1.1

94.91

98.26

0.24

341

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

563

5153

1.09

1.27

1.6

1.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

189

1621

1.16

1.27

1.2

65.91

52.14

u/ml

0.23

100

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

649

1.26

1.25

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

199

1717

1.16

1.24

1.1

23.58

20.51

au/ml

0.18

298

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

108

883

1.22

1.24

1.1

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

221

1922

1.15

1.24

1.4

22.35

29.98

iu/l

3.44

187

1595

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

212

1839

1.15

1.23

1.6

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

240

2101

1.14

1.23

3.1

3.7

5.21

13.37

nmol/l

1.47

231

2047

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

105

858

1.22

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

796

0.78

1.21

1.1

1.3

27.89

28.08

u/l

0.01

646

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

139

1.58

1.21

1.5

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

238

1.43

1.18

1.6

2.1

1.41

26.86

pmol/l

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

117

1.62

1.16

1.5

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

270

2393

1.13

1.16

2.4

2.7

54.34

766.26

u/ml

3.26

260

2362

(40768793) Breast Pathology biopsy report

276

2451

1.12

1.15

1.3

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.49

1.14

1.0

2.23

4.20

u/ml

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

107

883

1.21

1.14

1.8

1.5

5.66

6.31

u/l

0.72

752

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

126

1.58

1.12

1.5

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

831

0.79

1.12

1.4

1.5

—

(3004809) Band form neutrophils/Leukocytes in Blood

358

3232

1.11

3.2

3.7

1.26

1.60

1.11

329

2869

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

114

0.44

1.11

1.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.18

1.07

1.3

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

792

0.79

1.07

1.1

—

(3045424) Erythrocytes [Presence] in Urine

884

8301

1.07

1.06

2.1

2.2

0.11

0.13

estimate

0.05

292

2218

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

1.92

1.05

6.9

6.5

421.40

433.90

umol/l

—

(3025130) Human papilloma virus identified in Specimen

793

1.21

1.04

1.6

1.7

—

(3044927) Protein electrophoresis panel - Urine

233

2064

1.13

1.04

1.2

—

(3005570) Glucose [Moles/volume] in Urine

183

1596

1.14

1.03

2.1

1.9

—

1.04

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

2.27

1.03

1.0

1.1

—

26.24

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

677

1.22

1.02

1.2

1.5

24.18

21.80

umol/l

0.28

624

(3023410) Appearance of Cerebral spinal fluid

119

1395

0.85

1.01

1.7

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1001

9456

1.06

1.01

2.4

2.5

25.45

23.05

au/ml

0.27

763

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

112

945

1.18

0.98

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

230

2045

1.12

0.98

1.1

1.2

28.91

6.61

u/ml

0.63

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

448

1.27

0.98

1.3

36.72

33.59

0.27

291

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.80

0.97

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

134

1150

1.16

0.96

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.63

0.96

2.1

2.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

765

1.20

0.95

6.2

7.1

309.19

137.35

ug/l

0.27

497

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.68

0.94

1.0

5.21

7.79

u/ml

0.34

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

914

8634

1.06

0.94

1.2

1.3

67.26

56.41

au/ml

0.63

588

(3043410) Blood group antigens tested for on Red Blood Cells

469

1.26

0.93

1.7

2.0

—

(4133840) Spirometry

355

1.29

0.92

1.1

1.2

—

(40768446) Kidney Pathology biopsy report

632

1.22

0.92

1.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

439

4047

1.08

0.92

1.2

49.23

44.84

u/ml

0.11

192

(3018291) Platelet Ab [Presence] in Serum

2.14

0.91

1.0

—

(4212803) Bone marrow aspirate examination

175

1.42

0.91

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

360

0.72

0.91

2.1

2.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

733

1.20

0.91

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

417

0.74

0.90

1.0

1.1

—

(44813793) Dust mix specific IgE antibody measurement

788

1.19

0.90

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

165

1446

1.14

0.90

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

134

1.49

0.90

1.0

1.1

1.92

1.76

umol/24h

0.36

134

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

359

0.72

0.89

2.1

2.0

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

230

0.65

0.89

1.0

1.2

48.50

50.21

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

101

0.49

0.89

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

332

1.29

0.87

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

385

1.27

0.87

2.2

2.4

1.00

0.99

ug/l

0.02

366

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

143

1246

1.15

0.86

1.1

5.81

3.80

eliau/ml

0.34

430

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

424

0.75

0.86

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

435

0.76

0.85

2.1

2.4

110.79

672.54

ug/l

1.18

435

(3051387) C reactive protein [Mass/volume] in Capillary blood

372

3420

1.09

0.85

4.7

3.5

28.63

29.89

mg/l

0.27

269

2431

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

865

0.83

0.85

1.7

1.8

323.73

322.04

mu/l

0.02

675

(3044009) aPTT.lupus sensitive (LA screen)

1.56

0.83

1.4

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

111

0.54

0.83

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.73

0.82

1.1

1.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.87

0.81

1.2

1.1

7.63

8.53

mmol/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

386

0.75

0.81

1.1

1.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

113

1.50

0.81

4.8

5.2

—

(40768800) Prostate Pathology biopsy report

569

5332

1.07

0.79

1.2

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

172

1.39

0.79

1.8

1.5

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.79

0.0

1.1

—

1843.75

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.79

0.0

1.0

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

364

1.26

0.79

1.2

1.96

2.96

umol/l

1.73

309

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.79

0.0

2.4

—

96060.00

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

276

1.30

0.78

2.9

3.7

7.98

7.65

mg/l

0.14

225

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

181

1.38

0.78

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.51

0.78

1.0

1.3

212.80

356.37

umol/24h

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.66

0.77

1.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.53

0.77

2.5

3.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

683

1.18

0.77

1.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

412

3826

1.08

0.76

1.2

3.42

5.50

u/ml

0.52

385

(3006270) Folate [Moles/volume] in Blood

147

1298

1.13

0.76

1.2

324.53

336.09

nmol/l

0.28

113

1021

(3003740) Influenza virus B Ag [Presence] in Specimen

163

1449

1.12

0.75

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

363

3358

1.08

0.74

1.2

8.68

5.37

u/ml

0.21

235

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.51

0.74

1.1

1.29

1.05

u/field

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

144

1272

1.13

0.74

1.3

1.4

1.26

1.19

promille

0.22

113

1005

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

603

1.19

0.74

1.2

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

125

1095

1.14

0.73

1.2

9.50

9.81

mmol/l

0.32

114

1009

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

676

0.83

0.73

1.6

2.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

439

4675

0.93

0.73

4.7

4.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

159

0.63

0.72

1.6

1.9

17.32

18.21

umol/l

—

159

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

675

0.83

0.72

1.6

2.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

411

3828

1.07

0.71

1.2

1.3

13.20

5.95

u/ml

0.75

578

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

182

0.66

0.71

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.74

0.71

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.61

0.70

1.2

1.3

1.42

1.29

1.22

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

104

904

1.15

0.69

2.1

15.13

16.22

nmol/l

0.89

837

(3016018) Differential panel - Cerebral spinal fluid

150

1670

0.89

0.68

1.5

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

118

1037

1.14

0.68

5.1

5.8

82.22

71.81

u/ml

0.06

341

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

462

0.80

0.67

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

214

0.70

0.66

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

144

1.39

0.66

1.5

1.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.54

0.66

1.0

1.1

0.35

0.03

u/ml

—

(3033086) Enterovirus Ab [Titer] in Serum

1.62

0.66

1.0

—

(40768441) Liver Pathology biopsy report

130

1152

1.13

0.66

1.3

—

(3008898) HLA-B27 [Presence]

326

3022

1.08

0.66

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

202

2207

0.91

0.65

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

163

1800

0.90

0.65

3.0

3.8

28.37

40.29

u/ml

1.35

157

1746

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

178

0.67

0.65

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.59

0.65

1.1

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

870

0.86

0.64

1.1

—

(3022475) Manganese [Moles/volume] in Blood

1.61

0.64

1.2

1.4

0.14

0.16

umol/l

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.61

0.64

1.0

120.20

178.21

pmol/l

—

(3038026) Centromere Ab [Units/volume] in Serum

109

1229

0.88

0.63

1.2

54.04

47.73

u/ml

—

(3028707) Methadone [Presence] in Urine by Screen method

877

0.86

0.62

2.0

2.7

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

104

1.44

0.61

2.9

2.2

19.13

22.63

mg/l

0.65

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

747

0.85

0.60

1.1

—

11.02

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

682

0.85

0.60

1.5

2.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.59

0.0

1.9

—

223.45

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

198

2151

0.92

0.59

1.4

—

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.58

0.0

1.1

—

80.67

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.58

0.0

2.3

—

(40758358) Immune stain study

1.50

0.58

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

253

0.75

0.58

1.1

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

200

2167

0.92

0.57

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

374

0.80

0.56

1.3

1.8

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

613

1.16

0.56

1.9

1.8

2500.62

40665.54

u/ml

1.36

(3027923) C peptide [Moles/volume] in Serum or Plasma

1015

0.88

0.55

1.3

1.39

1.20

nmol/l

0.92

746

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

158

0.69

0.53

1.7

2.6

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

670

0.86

0.51

1.1

1.2

58.50

60.04

0.05

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

788

1.13

0.50

1.2

1.5

0.15

0.20

nmol/l

1.08

557

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

489

1.16

0.50

1.2

131.73

133.18

nmol/l

0.03

348

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

206

1.26

0.49

1.1

1.0

0.37

0.74

u/ml

0.37

199

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

192

2067

0.93

0.49

1.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.55

0.48

1.0

1.2

—

mmol/l

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

104

933

1.11

0.48

1.0

1.1

6.85

7.91

nmol/l

0.08

195

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.52

0.48

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.48

0.47

1.1

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

165

0.72

0.47

1.1

2.9

7.02

7.84

mmol/l

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

193

2070

0.93

0.46

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

187

0.75

0.46

1.9

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

192

2059

0.93

0.46

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

182

1954

0.93

0.45

3.2

3.9

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

485

1.15

0.45

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

485

1.15

0.45

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

485

1.15

0.45

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

485

1.15

0.45

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

342

3232

1.06

0.45

1.5

1.6

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

174

1.26

0.44

1.1

1.7

1.03

1.12

mmol/l

0.05

109

(3038177) Helicobacter pylori Ab [Presence] in Serum

200

1860

1.07

0.43

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

457

0.85

0.43

1.0

1.1

—

(3022621) pH of Urine by Test strip

1258

12221

1.03

0.43

3.1

2.9

5.96

6.01

1.47

943

8638

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

499

0.86

0.42

1.0

1.1

1.49

5.98

u/ml

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

348

3298

1.05

0.42

1.3

1.5

1.02

0.86

nmol/l

2.80

290

2765

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

391

0.84

0.42

1.7

1.6

0.39

0.40

ug/l

0.05

260

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.63

0.42

5.2

5.1

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.41

0.0

1.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.41

0.0

1.2

—

0.48

—

(3045177) Copper [Moles/volume] in Urine

0.00

0.41

0.0

1.1

—

0.19

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

571

0.87

0.41

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

158

1.26

0.40

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

539

0.87

0.40

1.1

—

(3035060) Mercury [Moles/volume] in Blood

0.00

0.40

0.0

2.3

—

16.63

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

226

0.79

0.39

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

180

1919

0.93

0.39

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

148

0.74

0.39

1.2

1.5

—

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

0.08

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

103

938

1.10

0.39

2.8

2.7

33.74

36.46

0.72

509

(3010937) Rubella virus Ab [Presence] in Serum

1.38

0.38

1.2

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

127

1369

0.92

0.37

1.4

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

177

1884

0.94

0.37

1.7

2.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

235

0.81

0.37

1.1

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

233

1.20

0.37

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.34

0.37

1.4

1.5

52.78

55.43

ug/l

0.09

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.34

0.37

3.2

2.2

—

(3028300) Cannabinoids [Presence] in Urine

179

1903

0.94

0.37

1.7

2.1

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.42

0.35

1.0

1.3

2.12

2.01

mg/l

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

222

0.81

0.35

1.8

2.6

—

(3027008) Opiates [Presence] in Urine

179

1898

0.94

0.35

1.7

1.9

—

(40763590) HLA-DQ beta [Type]

1.33

0.33

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

253

0.83

0.33

1.0

1.5

2.25

2.02

ug/l

—

145

(40760409) HLA-A [Type] by High resolution

1.30

0.33

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.30

0.33

1.0

—

(40760410) HLA-B [Type] by High resolution

1.30

0.33

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

145

1.24

0.33

1.4

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1081

10535

1.02

0.32

1.4

—

(3013862) HLA-DP [Type]

1.27

0.32

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

183

1.20

0.31

1.6

1.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

588

0.90

0.30

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

295

1.15

0.30

1.3

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

239

1.17

0.30

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

141

0.78

0.30

1.2

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

105

973

1.08

0.29

2.4

2.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

387

0.88

0.29

1.1

1.0

0.41

1.23

u/ml

0.85

(4198724) Urine methamphetamine measurement

296

1.15

0.29

1.3

2.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

496

1.11

0.28

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

167

1577

1.06

0.28

1.1

1.86

3.17

0.87

166

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

884

0.92

0.27

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

884

0.92

0.27

1.4

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.31

0.27

1.8

1.7

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

458

0.89

0.27

1.1

1.3

34.30

24.52

—

(40765096) Chromosome analysis panel by Banding

574

1.09

0.27

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

574

1.09

0.27

1.1

47.13

21.32

u/ml

1.34

185

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

934

0.93

0.27

1.5

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

934

0.93

0.27

1.5

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

934

0.93

0.27

1.5

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

934

0.93

0.27

1.5

1.8

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

140

1.21

0.26

1.2

1.3

11.64

10.05

mmol/l

1.56

134

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

299

2871

1.04

0.26

2.0

1.9

24.32

25.44

ug/l

0.14

291

2808

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.26

0.25

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

226

2158

1.04

0.25

1.4

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

234

1.15

0.25

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

146

1536

0.95

0.25

3.1

3.0

90.88

42.71

mg/l

0.55

101

1125

(3045683) HLA typing for celiac disease panel - Blood or Tissue

529

1.09

0.25

1.0

—

(3028433) Virus identified in Specimen by Culture

510

1.09

0.25

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

244

1.14

0.25

1.0

1.3

44.06

44.39

mg/l

0.01

208

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

137

0.80

0.24

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

180

0.83

0.24

1.3

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

153

1449

1.05

0.24

1.2

7.89

7.79

mmol/l

0.13

130

1211

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

147

1391

1.05

0.24

1.7

2.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.74

0.24

1.0

—

(3006462) Nitrate [Presence] in Urine

742

1.08

0.24

3.9

3.5

—

(3033099) Centromere Ab [Titer] in Serum

359

0.89

0.24

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

454

1.10

0.24

1.1

1.2

22.27

13.33

pmol/l

0.91

174

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

327

0.88

0.23

1.1

1.2

—

(4015189) Microbial culture of sputum

512

1.09

0.23

2.0

2.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

115

1.21

0.23

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.28

0.22

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.28

0.22

1.0

1.1

4.20

2.56

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.77

0.22

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

514

4999

1.03

0.22

3.2

4.2

100.52

87.09

u/ml

0.18

495

4799

(3014133) Dog dander IgE Ab [Units/volume] in Serum

111

1046

1.06

0.22

1.0

1.1

1.62

2.51

u/ml

1.00

519

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.26

0.21

11.5

9.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

769

0.93

0.21

4.7

6.0

40.10

5337.87

u/ml

—

128

(3005011) Chlamydia sp Ab [Titer] in Serum

144

1.18

0.21

1.6

1.7

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

164

1708

0.96

0.21

1.1

1.2

31.00

40.51

u/ml

0.26

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

102

0.78

0.21

1.1

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

107

1.21

0.21

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.16

0.21

1.0

1.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

334

0.90

0.20

2.5

5.1

103.20

63.21

u/l

0.32

324

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

217

2244

0.96

0.20

1.1

12.10

555.47

iu/ml

1.03

413

(3026389) Candida sp identified in Specimen by Organism specific culture

213

2046

1.04

0.20

1.3

1.4

—

(3016879) Cocaine [Presence] in Urine

171

1777

0.96

0.20

1.7

2.1

—

(3024869) Neuronal Ab [Presence] in Serum

344

1.10

0.20

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.20

0.19

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

837

1.06

0.19

3.3

3.6

1.24

1.28

0.07

837

(3028717) Thiamine [Mass/volume] in Blood

196

0.86

0.19

1.2

1.1

62.59

63.70

ug/l

0.12

196

(3036670) Protein [Mass/volume] in Synovial fluid

615

1.07

0.19

1.3

36.82

40.47

g/l

1.09

308

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

1020

0.95

0.19

2.1

2.4

0.54

0.60

e9/l

0.75

959

(3051101) Glucose [Moles/volume] in Cord blood

342

0.90

0.19

5.3

6.1

8.17

8.64

mmol/l

0.48

342

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

434

4226

1.02

0.18

3.0

3.4

688.98

1110.82

u/ml

0.58

383

3846

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

164

1571

1.04

0.18

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

164

1571

1.04

0.18

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

164

1571

1.04

0.18

1.5

1.6

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.13

0.18

6.3

4.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

121

0.82

0.18

1.1

—

(3003129) Base excess in Capillary blood by calculation

246

2378

1.03

0.18

2.3

2.4

0.19

0.39

mmol/l

0.39

239

2284

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

163

0.86

0.17

1.4

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

205

0.88

0.17

1.1

1.0

0.45

0.53

u/ml

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

261

1.11

0.17

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

338

1.09

0.17

1.1

1.2

0.71

64.77

mg/l

1.51

255

(40758292) HTLV I+II Ab panel - Serum

267

0.90

0.17

1.2

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

387

1.08

0.16

1.4

1.6

10.08

9.73

ug/l

0.16

387

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

130

0.84

0.16

1.0

1.1

—

(44806071) Cardiolipin IgM antibody measurement

167

1.13

0.16

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

235

2276

1.03

0.16

2.6

2.1

26.40

27.33

mg/l

0.12

821

(3027944) Amphetamines [Presence] in Urine

180

1855

0.97

0.16

1.7

2.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

174

1677

1.03

0.16

1.6

2.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

120

1.16

0.15

1.0

1.1

6.44

6.36

mmol/l

0.19

120

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

223

0.89

0.15

1.4

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

117

1214

0.96

0.15

1.1

0.68

0.97

u/ml

0.36

625

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

162

1669

0.97

0.14

1.1

1.02

1.42

u/ml

0.51

924

(3015076) Soybean IgE Ab [Units/volume] in Serum

326

0.92

0.14

1.1

1.0

0.65

1.13

u/ml

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

896

1.05

0.14

1.2

239.20

386.98

u/l

1.57

829

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

916

1.05

0.14

2.4

181.08

250.51

e6/l

3.48

803

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

381

1.07

0.14

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

180

0.89

0.13

1.3

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

180

0.89

0.13

1.3

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

344

0.93

0.13

1.4

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

102

980

1.04

0.12

1.0

1.1

0.69

2.78

u/ml

5.47

435

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

903

1.04

0.11

2.4

2.3

406.00

534.60

e6/l

1.61

737

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

124

1.13

0.10

1.0

1.1

9.39

11.35

u/l

0.27

124

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

412

0.94

0.10

1.5

1.3

0.30

0.31

g/l

0.50

331

(3014271) Vancomycin [Susceptibility]

103

1059

0.97

0.10

3.2

3.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

887

0.97

0.09

1.0

0.09

0.39

u/ml

1.31

331

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

735

0.96

0.09

1.0

1.1

12.60

9.76

iu/ml

0.31

168

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

113

0.88

0.08

1.1

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

132

1348

0.98

0.08

1.0

1.1

0.39

1.00

u/ml

2.18

583

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

154

0.91

0.08

5.4

5.7

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

1.05

0.08

1.7

4.30

1.85

mg/l

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

662

0.96

0.08

2.2

2.4

51.64

54.76

umol/l

0.30

565

(40762814) Titanium [Mass/volume] in Blood

358

0.95

0.08

2.6

2.4

2.92

3.56

ug/l

0.99

134

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.82

0.08

1.0

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

164

0.91

0.08

1.4

1.5

1.10

1.14

ratio

—

103

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

164

0.91

0.08

1.4

1.5

0.68

1.21

ratio

—

103

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

164

0.91

0.08

1.4

1.5

0.83

0.96

ratio

—

103

(3030313) Adrenal Ab [Titer] in Serum

0.79

0.08

1.0

1.1

—

12.29

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

174

0.92

0.08

1.4

2.3

2.69

10.35

ug/l

—

(3017509) Phencyclidine [Presence] in Urine

1.07

0.08

1.3

1.4

—

(4034850) Laboratory test

477

4705

1.01

0.07

16.2

11.9

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.83

0.07

1.0

1.1

201.67

261.90

nmol/l

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.82

0.07

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

163

0.92

0.07

1.2

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

137

1.09

0.07

1.1

1.92

3.20

u/ml

0.20

110

(3018851) Theophylline [Moles/volume] in Serum or Plasma

183

0.93

0.07

1.6

58.47

45.62

umol/l

0.59

183

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.86

0.06

1.1

1.7

—

(3009015) Lactate [Moles/volume] in Synovial fluid

213

0.94

0.06

1.2

1.3

6.99

6.82

mmol/l

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

192

0.93

0.06

1.1

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

670

6722

0.99

0.05

1.9

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

115

1166

0.98

0.05

1.3

1.4

167.45

172.94

pmol/l

0.19

115

1166

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

170

0.94

0.04

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

130

1277

1.01

0.04

1.3

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

180

0.94

0.04

1.4

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

137

1385

0.99

0.04

1.0

1.1

1.79

3.19

u/ml

1.22

679

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

291

2876

1.01

0.04

1.2

1.1

9.16

10.53

eliau/ml

0.17

238

(3019420) Tryptase [Mass/volume] in Serum or Plasma

683

1.02

0.04

1.8

1.5

17.21

10.43

ug/l

0.56

632

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

278

1.04

0.04

1.4

1.6

8.43

1.47

u/ml

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

108

0.92

0.03

1.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

177

1780

0.99

0.03

1.3

1.65

1.44

nmol/l

1.52

159

1615

(1001926) Buprenorphine [Presence] in Urine by Screen method

148

1461

1.01

0.03

1.7

2.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.08

0.02

1.0

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

127

1253

1.01

0.02

1.3

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

102

1.08

0.02

1.1

125.09

102.90

titre

0.34

102

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

117

0.94

0.02

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

141

1394

1.01

0.02

2.0

2.1

1.20

1.66

u/field

0.96

760

(3025018) Bordetella pertussis Ab [Titer] in Serum

657

0.99

0.01

1.1

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

282

1.03

0.01

1.6

1.5

888.72

1023.36

mu/l

0.26

222

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

153

1.04

0.01

1.1

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

176

0.96

0.01

1.5

1.4

909.22

281.56

mg/24h

—

(3020874) Milk IgE Ab [Units/volume] in Serum

415

0.98

0.00

1.1

1.10

1.09

u/ml

0.00

141

(4211845) Urine protein measurement

811

1.01

0.00

3.8

3.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

728

7250

1.00

0.00

2.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

168

1.01

0.00

1.0

1.1

39.71

38.36

iu/ml

0.03

168

(3034092) Cytoplasmic Ig cells/cells in Blood

157

1.02

0.00

9.9

10.5

0.20

0.23

0.42

157

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

190

1.00

0.00

2.6

2.9

0.53

0.42

u/field

0.20

190

(3023511) Choriogonadotropin [Units/volume] in Urine

219

1.00

0.00

1.5

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

328

1.00

0.00

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

125

1.04

0.00

1.5

1.9

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

175

1.03

0.00

1.4

1.7

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

105

0.95

0.00

3.1

48.00

43.34

—

105

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

153

0.98

0.00

1.0

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

104

0.96

0.00

6.2

6.3

8.10

8.11

—

104

(40762887) Creatinine [Moles/volume] in Blood

145

1.03

0.00

1.6

1.5

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.0

1.1

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.00

0.00

1.3

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

0.00

0.0

1.9

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

17.17

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.96

-0.00

1.4

1.1

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.5

—

4.67

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

4.28

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

155.20

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.00

-0.00

1.2

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.92

-0.00

1.0

—

(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

56.67

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.8

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.96

-0.00

1.2

1.5

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

6.82

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

-0.00

0.0

1.0

—

12.30

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CARDIOVERSION – Cardiodefibrillation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cardiodefibrillation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Cardiodefibrillation (CARDIOVERSION)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints